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ABSTRACT 
Lindsay Reine Walton: Developing Methodologies to Explore Neurovascular Coupling on a 
Micron Scale  
(Under the direction of R. Mark Wightman) 
 
During brain activity, local oxygen and glucose is consumed and cerebral blood flow 
(CBF) increases in a process known as functional hyperemia or neurovascular coupling. 
Neurotransmission releases molecules that respond through post-synaptic neurons, astrocytes, 
and cerebral blood vessels to stringently regulate CBF supply according to local demand. If 
coupling between metabolic supply and demand is not met, energy deficits can lead to toxin 
accumulation, pathology, and even cell death. Functional magnetic resonance imaging (fMRI) is 
a popular method used to monitor neurovascular regulation and study brain functionality. 
However, recent studies show that the neurovascular heterogeneity can produce decoupled 
hyperemia at high spatial resolutions in healthy subjects, making interpreting fMRI data less 
certain and necessitating a better understanding of the underlying mechanisms behind 
neurovascular coupling.  
Here, we developed additional tools with which to probe neurovascular coupling at highly 
localized environments. We adapted an existing CBF measuring technique to a microfabricated 
format and proved its functionality through mathematical modeling and in vitro verification. Next, 
we adapted a multimodal sensor to detect oxygen changes and neuronal activity resultant of 
local, chemically selective glutamate stimulation using iontophoresis. Comparing glutamate 
iontophoresis to electrically stimulated glutamate release revealed key differences between the 
local cerebrovascular responses to stimuli of different specificities and intensities. We extended 
the multimodal sensor to modulate local glutamatergic receptor pharmacology and discovered 
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that glutamate exerts influence on neurovascular coupling differentially between the 
somatosensory cortex and the nucleus accumbens.  
These tools provide alternative ways to measure multiple physiological metrics related to 
neurovascular coupling simultaneously. Our multimodal sensors offer chemical and spatial 
selectivity, and can assess neurovascular changes throughout the brain with minimal 
invasiveness. Together, our work demonstrates the importance of considering brain 
heterogeneity at the local level in the interpretation of more broad brain functionality studies.  
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CHAPTER 1: MUCH ADO ABOUT NEUROVASCULAR COUPLING 
 
Introduction 
Neurons are cells in the brain that communicate both electrically and chemically with 
other neurons, blood vessels, and a host of additional cell types. These signals propagate 
throughout the brain and periphery to accomplish tasks that range from recalling memories to 
kicking a ball. Neurotransmission and the upkeep of neuronal processes requires an astonishing 
amount of effort, consuming 20% of the body’s total resting energy (Rolfe and Brown, 1997). 
This energy predominantly derives from oxygen and glucose, but these metabolic substrates 
are not stored within the brain for access during times of increased activity. This is essential for 
the continued ability to maintain healthy cognitive function. If neurons are deprived of metabolic 
fuel, they will be unable to maintain ionic gradients. This leads to extensive cellular 
depolarization, excitotoxic buildup of glutamate, and eventual cell death.  
In 1890, scientists Roy and Sherrington published their seminal hypothesis that cerebral 
blood flow (CBF) renewed energy supplies to local brain regions with increased neuronal activity 
(Roy and Sherrington, 1890). This process was called functional hyperemia, also known also as 
neurovascular or cerebrovascular coupling. Since then, several breakthroughs in neurovascular 
coupling research have been made. Originally, CBF was proposed to respond to local 
decreases in oxygen or glucose in a negative feedback loop, until vasoactive species released 
from neurotransmission or downstream processes were found to communicate these needs 
(Attwell et al., 2010). Decades passed before astrocytic glial cells were found to influence 
vascular regulation, even forming a physical bridge between neurons and blood vessels to 
collectively form a “neurovascular unit” (Iadecola and Nedergaard, 2007). Astrocytic processes 
were found in close contact with presynaptic and postsynaptic neurons, together forming a hub 
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of neurovascular communication now known as the tripartite synapse (Araque et al., 1999). 
Even more recently, the spatial extent of neuronal activation was found to depend on stimulus 
intensity and revealed new insights into neurovascular decoupling at the local, cellular level 
(Thompson et al., 2004, O’Herron et al., 2016). However, many underlying factors of 
neurovascular coupling are still poorly understood.  
Studying neurovascular coupling encompasses the study of neuronal and astrocytic 
activity, CBF, oxygen dynamics, and the rates of oxygen and glucose metabolism. Each aspect 
can be monitored using multiple techniques, and the spatiotemporal resolutions between 
techniques differ. This is important because different neurovascular environments that dictate 
responses at the local level can invalidate the assumption that coupling is uniform across 
different brain regions. In addition to differences in detection, the stimulus used to elicit a 
cerebrovascular response can vary from visual (e.g., viewing a moving checkerboard pattern), 
to tactile (e.g., tail pinch), or electrical (e.g., deep brain stimulation). Together, coalescing the 
disparities between the data collection techniques and stimuli used, as well as the brain 
region(s) explored makes it difficult to interpret the specifics of neurovascular studies. 
Regardless of these inherent difficulties, it is imperative that neurovascular coupling research 
continue to be studied so as to better understand the underlying factors behind implicated 
pathologies and hone in on prospective therapeutic targets. 
This introduction serves to establish the importance of studying neurovascular coupling 
and to explain the techniques used to study this concept. First, we describe differences between 
healthy and pathological states of cerebrovascular decoupling. Next, we explore the main 
methods used to measure neurovascular coupling components at a large scale, and then their 
localized, spatially specific counterparts. Finally, we summarize what combinations have been 
performed between the differentially scaled technologies. 
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Neurovascular Decoupling and Pathology 
For nearly a century after Roy and Sherrington first discussed functional hyperemia, it 
generally was accepted that healthy brains tightly coupled CBF and metabolism to neuronal 
activity. If this process decoupled, it was seen as an indication of pathology. These pathological 
neurovascular dysfunctions range in severity from a complete CBF occlusion via ischemic 
stroke to the far subtler cortical spreading depression indicated in migraine (Lauritzen et al., 
2011). Indeed, numerous pathologies do exhibit signs of blood flow dysregulation or altered 
levels of metabolism. These include Alzheimer’s disease and dementia, among others (Girouard 
and Iadecola, 2006, Attwell et al., 2010, Zlokovic, 2011).  
Neurodegenerative diseases especially exhibit dysfunction in the form of impaired CBF 
delivery or glucose utilization, such that normal brain activity begins to run an energy deficit and 
accumulate harmful levels of carbon dioxide, reactive oxygen species, and other toxins 
(Zlokovic, 2011). Usually, vessels are protected by the blood brain barrier (BBB), a selectively 
permeable membrane of endothelial cells and pericytes that encompass and protect cerebral 
blood vessels from potentially harmful species. In addition to protecting these blood vessels, 
pericytes also modulate capillary diameters based on neuronal input (Peppiatt et al., 2006). 
Normally, these cells form tight junctions around the circumference of blood vessels that only 
allow passage of oxygen, carbon dioxide, and small, lipid soluble proteins into the brain 
parenchyma (Zlokovic, 2011). When this barrier is compromised, infectious agents may freely 
flow into the cerebral vasculature (Nelson et al., 2016). It is still unknown whether BBB injury is 
the starting point for neurodegenerative pathologies or a symptom resulting from changes 
elsewhere. 
In addition to the importance of neurovascular regulation within the brain, it is crucial to 
maintain healthy vascular regulation across the entire body. Diabetes, hypertension (Iadecola 
and Davisson, 2008), drug use, and many other conditions have been linked to an increased 
risk of neurodegenerative disease, along with age and genetic factors (Zlokovic, 2011, 
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Daulatzai, 2016). Comorbidity between these factors brings greater risk of dysfunctional 
neurovascular regulation, especially late in life. However, the relationship between systemic 
blood regulation and cognitive functionality can be advantageous. As many drugs do not readily 
pass through the BBB to locally access cerebral vasculature, indirect treatments such as anti-
hypertensive drugs (Hajjar et al., 2012) and even exercise (DeFina et al., 2013) have found 
success in ameliorating risk factors that contribute to neurodegenerative disease. The relation 
between systemic and cerebral circulation requires further study, necessitating the use of 
technology that can monitor blood flow dysregulation at both global and local resolutions. 
 
Dichotomy between Coupled and Decoupled States in Healthy Subjects  
Healthy human subjects were long assumed to couple CBF and metabolism increases 
with brain activity in support of the functional hyperemia dogma (Roy and Sherrington, 1890). In 
many cases, this is valid (Hoge et al., 1999, Uludağ et al., 2004), but technical challenges 
prevented anyone from proving otherwise until the advent of positron emission tomography 
(PET) imaging in the 1980s. Once PET paradigms were established, then CBF, cerebral blood 
volume (CBV) and oxygen extraction fractions (metrics comparing oxyhemoglobin conversion to 
deoxyhemoglobin) could be quantified using a series of three 15O tracers (Mintun et al., 1984). 
This led to the seminal 1986 publication first describing an uncoupled neurovascular response 
in healthy human subjects, turning the world of functional neuroimaging on its head (Fox and 
Raichle, 1986). Specifically, finger pad stimulation was found to elicit regional CBF increases 
that far surpassed what would have been expected from the simultaneous increase in 
metabolism. Ever since then, researchers have been attempting to establish the rhyme and 
reason behind neurovascular decoupling to distinguish the neurotypical from the 
neuropathological.  
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Knowing the difference between normal and detrimental neurovascular decoupling is 
critical knowledge when interpreting brain functionality studies (Logothetis, 2003, Uğurbil et al., 
2003). The most prolific technique used for these studies is functional magnetic resonance 
imaging (fMRI), which relies on the assumption that neurovascular coupling is conserved when 
attributing changes in blood flow or oxygen to brain activity. Without directly monitoring neuronal 
activity, this assumption may not be valid across brain regions with different metabolic behavior 
(Sloan et al., 2010). As detailed later in this chapter, to truly study functional hyperemia 
dynamics necessitates the use of several techniques in concert, each measuring a different 
change. Experimental design requires careful consideration not only of the techniques to be 
used, but the protocol to elicit a functional response. Advancements in technology have led to 
highly specific means of both stimulating and recording functional hyperemia, and we are only 
beginning to understand the differences behind localized and larger scale cerebral responses. 
  
Population-Level Detection 
To study neurovascular coupling is to study a simultaneous cascade of events that 
operate on different timescales and produce downstream effects. Unfortunately, many ways to 
detect the relevant metrics related to neurovascular coupling are also invasive. Thus, to ethically 
study neurovascular coupling in humans requires non-invasive methods. While these 
techniques are unable to determine specific underlying processes, they are able to collect 
measurements without compromising the brain tissue. Here, we briefly describe the most 
common techniques used to study neurovascular coupling at a large spatial scale. 
 
Cellular Activity 
 Electroencephalography - Neurons fire when their ionic gradients sufficiently perturb 
membrane potentials towards a threshold value, past which the cell depolarizes and fires an 
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action potential. At a small scale, this excitatory firing temporarily establishes a charged dipole 
along the neuron. Electroencephalography (EEG) positions multiple electrodes across the scalp 
to monitor this electrical activity. Individually, these signals are too weak to detect through dura, 
skull, and skin. These physical barriers serve as insulation between the electrode charges and 
the charges accumulated through synaptic firing; effectively, this system acts as a capacitor 
(Jackson and Bolger, 2014). Eventually, these charges propagate through to the electrodes. 
EEG typically is used to diagnose pathologies that disrupt the natural oscillations of brain 
activity, such as epilepsy. Its spatial resolution is poor and it can neither detect subcortical brain 
activity nor target the source of the cortical signals that it does detect. Despite these 
disadvantages, the low cost, ready use with other techniques, and millisecond time resolution 
ensure that the technique is still widely used in both preclinical and clinical studies.   
 Magnetoencephalography - Magnetoencephalography (MEG) is a technique similar to 
EEG, but that takes advantage of the magnetic field generated from neuronal activity rather than 
the buildup of charge. The collective neuronal electrical currents from activity induce a weak 
magnetic field in accordance with Maxwell’s equations. To detect these magnetic fields, which 
are ~10-9 gauss in comparison to the ~0.5 gauss exerted by the earth’s magnetic field (Cohen, 
1972), requires sensitive superconducting quantum interference devices to transduce magnetic 
signals into voltage. These sensors must be kept at 4.2 K temperatures and operate in a heavily 
shielded room to avoid environmental noise (Pizzella et al., 2014). Like EEG, its uses are mostly 
related to observing the oscillatory dynamics of brain activity at a millisecond scale to diagnose 
pathologies, but MEG boasts superior spatial resolution that can aid in the location of brain 
tumors prior to surgery (Pizzella et al., 2014). 
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Oxygen  
BOLD fMRI – The gold standard of detecting global oxygen usage throughout the entire 
brain is blood oxygenation level dependent (BOLD) fMRI. This technique capitalizes on the 
different magnetic properties of diamagnetic oxyhemoglobin versus the paramagnetic 
deoxyhemoglobin to map hemodynamic responses (Ogawa et al., 1990). During a BOLD scan, 
radiofrequency (RF) pulses uniformly align the magnetic poles of 1H nuclei (Plewes and 
Kucharczyk, 2012), which then relax in a predictable manner. As neuronal activity consumes 
energy, oxyhemoglobin becomes deoxyhemoglobin and thereby distorts these local magnetic 
fields (Harris et al., 2011). Greater neuronal activity presumably consumes more oxygen, 
resulting in a greater disturbance in the magnetic field and thus increased BOLD signals.  
This technique is completely non-invasive, images the whole brain at once, and can be 
used to obtain as many scans per experiment as the subject allows. The spatial resolution 
typically is a 1-3 millimeter pixel cube, known as a voxel, and the temporal resolution is on the 
order of seconds (Harris et al., 2011). Studies range from monitoring the severity of a traumatic 
brain injury (Belanger et al., 2007) to tracking the effects of a psychotic stimulant (Carhart-Harris 
et al., 2012). The popularity of BOLD has ensured that its shortcomings are equally well known 
and accounted for regarding data interpretation (Ekstrom, 2010). Combining BOLD with other 
techniques will continue to provide additional physiological context to data interpretation as it 
relates to neurovascular coupling. 
 
Metabolism  
PET – As neurons fire, they consume glucose and oxygen to produce carbon dioxide 
and water. PET is the gold standard technique for measuring the cerebral metabolic rates of 
glucose (CMRglc). A glucose analog labeled with a positron emitting radioisotope 
([18F]fluorodeoxyglucose, FDG) is intravenously administered. FDG is transported into brain 
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tissue through glucose transporters at the BBB, and is phosphorylated by hexokinase without 
being further metabolized to pyruvate. Thus, the radiolabel accumulates in areas of high 
glucose metabolism. Ultimately, the resulting gamma rays produced from positron and electron 
annihilation from the radiolabeled FDG are detected to quantify metabolic activity from 
glycolysis (Mosconi, 2013). Metabolism can be monitored anywhere in the body using this 
technique. The spatial resolution of PET is ~2-7 mm (Mosconi, 2013), and the scan times are 
slower than fMRI BOLD scans. As with fMRI, PET scanners and their upkeep are also costly. 
Nevertheless, the customization possible with PET makes it valuable for many purposes that 
range from detecting tumors to assessing neurotransmitter receptor activity (Volkow et al., 
1996).  
 
Blood Flow  
ASL fMRI – Arterial spin labeling (ASL) fMRI is a truer CBF measurement than BOLD 
fMRI, and can be acquired simultaneously with BOLD to offer complementary information (Liu 
and Brown, 2007). Using RF pulses to magnetically label water within arterial blood, ASL 
detects the perfusion of labeled water from capillary blood into tissue. Subtracting data collected 
in absence of magnetic labeling from a labeled scan quantifies CBF changes. It localizes 
capillary blood flow without convoluting results from oxygen metabolism or blood volume 
changes, which makes it ideal to quantify CBF changes resulting from neuronal activity (Liu and 
Brown, 2007). Although ASL has lower signal-to-noise ratio and poorer temporal resolution than 
BOLD, there is lower inter-experimental and inter-subject variability with ASL use (Golay et al., 
2004). Although combining BOLD and ASL fMRI provides information about oxygenation and 
CBF changes, it cannot discern the underlying causes (Bandettini, 2012). 
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Narrowing the Field of Detection 
The global techniques described have provided invaluable data regarding neurovascular 
data between pathological and healthy human subjects. However, studies must be performed at 
a local level to understand the neurovascular influence of specific cell types, receptors, and 
neurotransmitters in a given brain region. Low spatial resolution also averages out the natural 
heterogeneity of the brain, where differences in neuronal architecture may have a profound 
impact on hemodynamic responses. Additionally, the preclinical animal models used to study 
neurovascular coupling require high resolution techniques, as areas of interest could be far less 
than 1 mm2. Common methods capable of resolving neurometabolic components at high 
resolution, some even at the single cell level, are described below. 
 
Cellular Activity  
Electrophysiology – Microelectrodes detect extracellular neuronal activity at millisecond 
time resolutions through electrophysiological techniques: single-unit recording, multi-unit 
recording, and local field potentials (LFPs). These electrodes are placed within the brain and 
record action potentials as voltage changes, which are amplified and filtered. LFPs are 
analogous to spatially restrictive EEG recordings, but are acquired from electrodes placed within 
the brain that are not limited to the cortex. As with EEG, LPFs primarily monitor post-synaptic 
potential activity at 1-200 Hz frequencies and provide a more global view of brain waves. 
Filtering signals from 300-3,000 Hz instead isolates discrete action potentials or spikes from a 
single neuron, also known as single-unit activity (Reed et al., 2015). Single-unit recording 
requires high impedance (>2 MΩ) electrodes with low surface areas and precise positioning 
near a single neuron, whereas multi-unit recording electrodes are larger (often in array format), 
lower impedance, and collect information from multiple neurons (Coleman and Burger, 2015). 
As such, single-unit recordings are the ultimate high precision tool for monitoring neuronal 
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activity, but multi-unit recordings and LFPs sum multiple cells across hundreds of microns to 
address broader patterns of neuronal activity (Reed et al., 2015).  
 
Oxygen 
Amperometry – Oxygen electrochemically reduces at approximately -1.3 V (versus 
Ag/AgCl), a more cathodic potential than most other biologically-relevant molecules. Thus, 
microelectrodes can be inserted into the brain to selectively sense oxygen with minimal tissue 
damage. Constant potential amperometry holds an electrode at a sufficiently cathodic potential 
and measures the oxygen reduction current with millisecond time resolution. Absolute oxygen 
concentrations are quantified using a calibration plot. The common electrodes used are either 
platinum, Clark-type electrodes or carbon paste electrodes. Bare platinum fouls in vivo, and 
requires a membrane barrier between the tissue and the electrode surface. Meanwhile, carbon 
surfaces are resilient against biofouling and do not require any coatings. Carbon paste 
electrodes are >200 µm in diameter (Bolger et al., 2011) and platinum sensors are as small as 
3-5 µm in diameter (Offenhauser et al., 2005), making amperometry a viable option for both 
locally averaged tissue oxygen and oxygen at spatial scales sufficient to resolve individual 
capillaries, respectively.  
Fast-Scan Cyclic Voltammetry – Fast-scan cyclic voltammetry (FSCV) applies a 
waveform to a ~5-7 µm diameter carbon fiber. These waveforms scan across a voltage range at 
high scan rates (>100 V/s). Charging background current at the electrode scales with increasing 
scan rates, but its stability permits this nonfaradaic background current to be subtracted out to 
isolate the signal of interest.  The most common oxygen sensing waveform begins at 0 V, scans 
anodically to +0.8 V, cathodically to -1.4 V, and finally returns to 0 V (Zimmerman and 
Wightman, 1991). Anodic limits as high as +1.45 V are used to detect adenosine also (Wang 
and Venton, 2016). As with amperometry, absolute oxygen concentrations can be calculated.  
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The unique advantage of FSCV over amperometry is the ability to simultaneously detect 
oxygen and other electrochemically active biological analytes. When FSCV currents are plotted 
against potential, the resulting cyclic voltammogram shape can confirm the identity of an 
analyte. Among them, adenosine (Phillis, 1988), norepinephrine (Bucher et al., 2014), and 
serotonin (Cohen et al., 1996) are known to exert vasomodulatory effects. Principle component 
regression analysis can separate current contributions from multiple co-presenting analytes, 
making it possible to accurately quantify concurrent changes between oxygen and vasoactive 
neuromodulators with high spatial resolution. 
 
Metabolism  
 Two-Photon Fluorescence Microscopy – Nicotinamide adenine dinucleotide (NADH) 
serves as an electron carrier in glycolysis and oxidative metabolism processes, and 
nicotinamide adenine dinucleotide phosphate (NADPH) is a coenzyme regulated by glucose 
availability. These coenzymes are weakly autofluorescent, but the oxidized forms NAD+ and 
NAD+P are not. Utilizing the ~360 nm absorbance and ~460 nm emission wavelengths, 
metabolic changes at the cellular level are assessed through fluorescence measurements. Most 
often, two-photon fluorescence microscopy is used to avoid the harmful ultraviolet excitation 
wavelengths and instead excite NADH and NADPH with two infrared photons at ~720 nm 
(Piston and Knobel 1999). As local glucose concentrations rise, so too does the local 
fluorescence. This technique is used for acquiring immediate metabolic information at 
subcellular levels (Piston and Knobel, 1999, Kasischke et al., 2004), given the sub-micron 
spatial resolution and femtosecond laser excitation pulses (Murphy, 2013). Most importantly, 
two-photon fluorescence microscopy observes metabolism in fully intact tissue safely, even for 
minutes at a time without disrupting cell viability (Piston and Knobel, 1999).   
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Blood Flow   
 Laser Doppler Flowmetry – Laser Doppler flowmetry (LDF), also known as laser Doppler 
velocimetry, is the most common optical method used to monitor CBF changes. This method 
has commercially available tools (PeriFlux, Perimed AB, Sweden) that consist of two optical 
fibers: one fiber to direct a low powered laser beam at blood vessels, and the other to detect the 
reflected light. The motion of red blood cells flowing scatters the applied light such that the 
recorded light shifts in frequency according to the Doppler effect. The frequency shift is 
proportional to the CBF velocity. As such, this technique offers continuous, non-invasive CBF 
measurements. LDF cannot directly quantify CBF changes, but the relative changes measured 
correlate well with quantitative techniques (Hendel et al., 1983, Kvietys et al., 1985, Dirnagl et 
al., 1989). The depths assessed are on the order of millimeters (Nilsson et al., 1980), which 
permits superficial measurements only. The non-invasive, continuous flow measurements make 
this technique popular not only for cortical CBF measurements, but also cutaneous (Kastrup et 
al., 1989) and optical (Petrig et al., 1999) blood flow. 
Hydrogen Clearance – Gas clearance is an inexpensive alternative to optical methods, 
and is used to assess subcortical CBF or CBF in freely behaving animals (Lowry et al., 1997).  
Hydrogen is an inert gas that otherwise does not exist endogenously, and that oxidizes to 2 H+ 
(Young, 1980). Hydrogen gas is introduced into a subject through either an intravenous injection 
of hydrogen saturated saline, an extended hydrogen gas inhalation period, or in situ generation 
(Keller and Lübbers, 1972, Stosseck et al., 1974, Fellows and Boutelle, 1993). Once the tissue 
of interest is saturated, a platinum microelectrode held at +0.2 V (versus Ag/AgCl) detects 
amperometrically the exponential clearance of hydrogen from the tissue as a function of both 
CBF and diffusion. Flow is calculated by taking the ratio of a measurement without flow to a 
measurement with flow to eliminate the contribution of diffusion. The electrode size determines 
how local the measurements are, and range from 1-250 microns in diameter (Young, 1980). 
13 
 
Quantitative CBF changes are obtained, but these measurements are on the order of minutes 
apart (Young, 1980). 
 
Multiplexed Detection of Neurovascular Coupling 
With functional hyperemia involving so many biological domains, the ideal way to study it 
is by multiplexing techniques that measure different metrics to run concurrently. Unfortunately, a 
balance between electrical noise, strong magnetic fields, and physical equipment placement 
cannot always be achieved. Thus, many techniques run the same experimental paradigm twice 
using different techniques, which can have subtle or major flaws in reproducibility (Chen et al., 
2008). Researchers continue to develop simultaneous detection with some success, as with 
PET/fMRI (Pichler et al., 2010), hydrogen clearance and amperometry (Lowry et al., 1997), 
ASL/BOLD fMRI (Liu and Brown, 2007), and even electrophysiology combined with 
simultaneous LDF and amperometric oxygen detection (Offenhauser et al., 2005), among many 
other combinations. These exemplify instances where techniques of similar spatial and/or 
temporal resolution are used together; however, combinations such as amperometry and BOLD 
fMRI can assess both global and localized oxygen changes to elucidate differences and 
similarities between the two (Lowry et al., 2010).  
There are additional adaptations used to better understand neurovascular coupling 
mechanisms, but more is still needed. In lieu of observing neuronal activity, fMRI in particular 
has started to use optogenetic stimulations (Lee et al., 2010) to selectively activate known 
cellular populations as opposed to using less specific electrical or peripheral stimulations. Drugs 
are applied locally through iontophoresis to avoid systemic drug effects that could affect basal 
oxygen metabolism or vascular tone (Bucher et al., 2014). There are still gaps between 
technologies, such as the lack of a highly-resolved subcortical CBF measuring instrument and 
affordable, chemically selective neuronal excitation. To truly assess local versus global 
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neurovascular coupling and how it differs between specific and nonspecific stimuli, we address 
these gaps in this dissertation.  
 
Overview of Dissertation 
Understanding the underlying factors controlling neurovascular coupling is crucial with 
regards to interpreting a growing body of functional brain imaging studies. Technology has 
advanced both the number of techniques able to probe aspects of neurovascular coupling and 
the accuracy with which it can be done. While studies in humans normally are limited to non-
invasive methods with more global scopes of detection, animal models have been studied to 
narrow in on neurovascular interactions as far down as the cellular level. The first two aims of 
this dissertation address the need for a subcortical CBF sensor with a miniaturized adaptation of 
electrolytic hydrogen clearance sensors. The third aim establishes the importance of evoked 
responses from different stimulation types by comparing electrical stimulation to chemically and 
spatially selective excitation with glutamate. The fourth aim takes local stimulation a step further 
to investigate a method of studying both local stimulation and local pharmacological 
manipulation in discrete microenvironments. As the spatial and temporal resolution brain 
functionality techniques used in man continue to improve, natural neurovascular heterogeneity 
must be characterized before pathologies can be interpreted correctly from brain functionality 
data. 
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CHAPTER 2: DESIGN AND CHARACTERIZATION OF A MICROFABRICATED HYDROGEN 
CLEARANCE BLOOD FLOW SENSOR1 
 
Introduction 
Cerebral blood flow (CBF) increases in activated brain regions to deliver energy in the 
forms of glucose and O2 – a phenomenon known as functional hyperemia (Iadecola, 2004, 
Haydon and Carmignoto, 2006, Attwell et al., 2010). This increase also serves to maintain non-
cytotoxic levels of metabolic products and conserve physiological pH following neuronal activity. 
Disease states such as ischemia can dysregulate hyperemia and generate or perpetuate brain 
damage, as neurons become both deprived of energy substrates and exposed to toxic levels of 
neurotransmitters and metabolic products (Hossmann, 1994, Iadecola, 2004, Haydon and 
Carmignoto, 2006). Beneath the cerebral cortex, densely packed capillaries fine-tune CBF 
activity to maintain homeostasis (Iadecola, 2004, Attwell et al., 2010). A broad literature exists 
studying cortical CBF (Harper and Glass, 1965, Dirnagl et al., 1989, Takano et al., 2006), but 
studying microvasculature control in the deep brain can provide new insight into pathologies 
hallmarked by CBF dysregulation, as well as flow activity in the behaving brain.  
Numerous techniques have been used to measure CBF, including optical methods and 
tracer clearance approaches (Kety, 1951, Ter-Pogossian et al., 1970, Prinzen and 
Bassingthwaighte, 2000, Boas and Dunn, 2010, Shih et al., 2012). Laser Doppler flowmetry and 
laser speckle imaging are the most popular optical techniques, but the size of commercially 
                                                          
1 This chapter previously appeared as an article in the Journal of Neuroscience Methods. The 
original citation is as follows:  Walton LR, Edwards MA, McCarty GS, Wightman RM (2016) 
Design and characterization of a microfabricated hydrogen clearance blood flow sensor. J 
Neurosci Methods 267:132-140. 
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available probes (500 µm or greater in diameter) risks extensive tissue damage to areas below 
the cortical surface (Dirnagl et al., 1989, Dunn et al., 2001, Shih et al., 2012). Clearance 
techniques, which rely on detecting the transport of an inert tracer to quantify flow, can measure 
CBF throughout the brain.  However, these methods are costly (e.g. magnetic resonance 
imaging) and/or have a finite number of measurements per animal dictated by the number of 
unique labels available (e.g. fluorescent tags for microspheres) (Prinzen and Bassingthwaighte, 
2000, Edvinsson and Krause, 2002). Sensitivity to motion artifacts further excludes the most 
commonly used techniques, optical and magnetic resonance imaging, from CBF measurements 
in behaving subjects. As an increasing number of common anesthetics (e.g. isofluorane) are 
known to have vasoactive effects (Ueki et al., 1992, Lindauer et al., 1993, Matta et al., 1999), 
development of a technique capable of exploring deep within the brain during conscious activity 
is highly desired. 
Inert gases are attractive clearance tracers in biological subjects, as gas clearance can 
make an unlimited number of measurements per subject, detect CBF below the cortex, and 
perform in both anesthetized and freely-moving animals, all while quantifying CBF in ways that 
correlate highly with values obtained from competing techniques (Kety, 1951, Aukland et al., 
1964, DiResta et al., 1987, Fellows and Boutelle, 1993, Machens et al., 1995, Lowry et al., 
1997, Pell et al., 2003). The most affordable clearance gas is H2, introduced through inhalation, 
injection of H2-saturated saline, or electrolytic generation (Aukland et al., 1964, Stosseck et al., 
1974, Young, 1980). The lattermost, electrolytic H2 clearance (EHC), generates H2 in situ and 
monitors its clearance to measure blood flow. Using a collector-generator electrode array, inert 
H2 is generated galvanostatically from endogenous water and reoxidized at a potentiostatic 
collector electrode. Common biological interferents oxidize at higher potentials than H2, so a low 
collector potential ensures specificity for in vivo use (Young, 1980). Inhalation and injection H2 
clearance methods have poor temporal resolution, as gas takes minutes to permeate through 
tissues and saturate the brain for a single measurement (Meyer et al., 1972, Lowry et al., 1997), 
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whereas EHC generates gas locally and reduces saturation time to seconds (Stosseck et al., 
1974, Koshu et al., 1982). However, existing EHC electrodes are a millimeter or larger in 
diameter, too large for anything other than superficial CBF measurements (Stosseck et al., 
1974, Koshu et al., 1982, DiResta et al., 1987). Despite its superior temporal resolution, EHC 
has not been used for CBF detection in subcortical, freely-moving experiments due to the 
technical limitations of probe size. 
In this paper we use photolithography to fabricate a platinum electrode array capable of 
EHC that is an order of magnitude smaller than previous sensors (Stosseck et al., 1974, Koshu 
et al., 1982). Micron-scale dimensions improve spatial resolution and allow for sub-surface CBF 
measuring with minimal tissue damage. Microfabricated EHC fulfills the need for a tool capable 
of measuring CBF in the deep brain on a more physiological timescale than existing gas 
clearance methods, with the crucial benefit of applicability during freely-behaving experiments. 
Here, we characterize our EHC array, assess its suitability as a blood flow sensor, and present 
a theoretical framework for analyzing the data it produces.  
 
Experimental  
Chemicals and Solutions 
Chemicals were received from Sigma Aldrich (St. Louis, MO) unless otherwise noted.  
Phosphate buffered saline (PBS, 140 mM NaCl, 3 mM KCl, 10 mM NaH2PO4) was diluted from 
a 10x stock and adjusted to pH = 7.4 with 5 M NaOH on the day of use. Hexaamineruthenium 
(III) trichloride (RuHex) was dissolved in 0.1 M KCl. McIlvaine buffers were made on the day of 
use from 0.1 M citric acid and 0.2 M K2HPO4, according to the pH value desired. DL-
Noradrenaline hydrochloride (norepinephrine, NE) was added to buffer immediately prior to 
collecting rate data. All solutions were at 25 °C. 
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Platinum Electrode Array Fabrication 
Platinum EHC arrays (Figure 2.1A) were fabricated using instruments at both the North 
Carolina State University Nanofabrication Facility (NNF) and the Chapel Hill Analytical and 
Nanofabrication Laboratory (CHANL) at UNC Chapel Hill. The process used was similar to 
arrays that we previously reported (Dengler and McCarty, 2013). Silicon wafers (University 
Wafer, Inc., Boston MA) were insulated with silicon nitride (3000 Å) using low-pressure chemical 
vapor deposition (LPCVD). Photolithography was performed using a negative tone photoresist 
(NFR 016 D2, JSR Corp., Tokyo, Japan) following dynamic application of hexamethyldisilazane 
(HMDS) as an adhesion promoter to obtain a thickness of approximately 3.7 µm. After exposure 
and development of the photoresist, the nitride was dry-etched using reactive ion etching (RIE) 
to pattern trenches of approximately 600 Å. Titanium metal was evaporated over the entire 
wafer (200 Å) to aid adhesion between the LPCVD nitride and subsequently evaporated 
platinum (400 Å). Lift-off was achieved with acetone, followed by a standard RCA-1 clean.  
The arrays were insulated with silicon nitride (3000 Å) using plasma-enhanced chemical 
vapor deposition (PECVD). Photolithography using HMDS followed by S1813 positive tone 
photoresist (Shipley, Marlborough, MA) isolated areas of electrical exposure. The PECVD 
nitride was dry-etched through to the LPCVD nitride. A thick (>10 µm), protective layer of 
positive photoresist (AZ 4620, Shipley) was spun atop the wafer. Each wafer totaled 81 
individual devices with different array dimensions, 26 of which were the geometry described in 
this paper. Devices were ultimately isolated using a dicing saw. Electrical connections to contact 
pads were made manually under a microscope using stainless steel wire and silver epoxy (MG 
Chemicals, Canada). Platinum devices were cleaned via voltammetric cycling in 0.5 M H2SO4 
and were excluded from the study if the steady state current measured by slow-scan 
voltammetry in quiescent RuHex solution was not in agreement with that predicted by theory 
(finite element simulations). Platinum black coatings were applied to 3 devices, as previously 
described (Shin et al., 2008), to increase electrochemically active surface area. Carbon arrays 
25 
 
used for cyclization experiments were previously fabricated in the laboratory and had the same 
dimensions as the platinum devices used in this paper (Dengler and McCarty, 2013). 
 
Data Acquisition 
Custom hardware was assembled (UNC Chemistry Electronics Shop, Chapel Hill, NC) 
for galvanostatic control of the generator electrode.  Voltammetry data was collected with a 
Chem-Clamp potentiostat (Dagan Corporation, Minneapolis, MN) and filtered at 100 Hz. Carbon 
disk measurements were made using an EI-400 potentiostat (Ensman Instruments, 
Bloomington, IN). All data were acquired using custom, locally written LabVIEW (National 
Instruments, Austin, TX) programs with 60 Hz collection frequency. A Ag/AgCl wire reference 
was used and potentials reported herein are relative to this electrode. Galvanostatic generation 
was used to ensure consistent H2 production regardless of electrode fouling or surface changes 
that could affect the voltage response. Generator currents were -100 nA unless otherwise 
noted. The collector potential was held at +0.25 V. Between each galvanostatic pulse, the 
collector electrode was cycled briefly (2-4 s, 20 V s-1, from -0.5 V to +1.0 V) to maintain platinum 
surface integrity and collector current reproducibility. 
  
Norepinephrine Cyclization Experiments 
The rate of the cyclization of NE-orthoquinone (the oxidation product of NE) to leuco-
noradrenochrome was used to assess the suitability of the devices for detecting flow rates, 
using an experimental paradigm akin to that used in clearance data. Electrode arrays of 
identical geometry to the platinum electrode array, but with carbon electrodes, were used. The 
collector was held at 0.0 V, and the generator used 10 s, +100 nA pulses to oxidize NE to NE-
orthoquinone. Data were acquired in McIlvaine buffers of varying pH (7.40 - 8.05) before and 
after the addition of 100 µM NE. 
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The rate of cyclization in solutions of the same pH range was independently measured 
using potential step chronoamperometry at a glassy carbon disk (r = 1.5 mm) collected at 60 
Hz. The electrode was polished for 30 s with a 0.05 µm alumina slurry, rinsed with methanol and 
deionized H2O, and sonicated for 1 minute between each data collection to maintain 
consistency (Hu et al., 1985). Rates of cyclization for each pH were calculated as previously 
described (Hawley et al., 1967). 
 
Modeling 
Finite element modeling was used to calculate the spatially varying H2 concentration 
over time. At time T=0 the current at the generator was stepped from zero, i.e., no 
electrochemical reaction occurring, to a cathodic current, igen (taken to be negative in the 
following discussion), achieving the reduction reaction in Equation 1. The current returns to zero 
at time T*.  
 2 𝐻+ + 2 𝑒−  →  𝐻2 (1) 
The initial concentration of H2 was taken to be to be zero throughout the simulation 
domain. Mass transport was described by the time-dependent version of the reaction-diffusion 
Equation 2, which is solved in the three dimensions; X, Y and Z. 
 
𝜕𝐶
𝜕𝑇
= 𝐷∇2𝐶 − 𝜅𝐶 (2) 
C represents the concentration of H2, D = 5x10-5 cm2s-1 its diffusion coefficient (Macpherson and 
Unwin, 1997), T the time (s), and 𝜅 (s-1) the first order rate constant H2 clearance, as proposed 
by Stosseck et al. (Stosseck et al., 1974, Young, 1980). 
The boundary condition for the generator electrode is 
 𝐷∇𝐶 ∙ 𝑛 =  
𝑖𝑔𝑒𝑛(𝑇)
2𝐴𝐹
 (3) 
where 
 𝑖𝑔𝑒𝑛(𝑇) =  |
𝑖𝑔𝑒𝑛
0   
  ∀ 0≤ 𝑇 ≤ 𝑇
∗
 ∀ 𝑇<0 𝑎𝑛𝑑 𝑇 > 𝑇∗
 (4) 
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In these equations, ṉ is the inward pointing unit normal, F is Faraday’s constant and A is the 
generator electrode area. The factor of 2 arises from Equation 1 stoichiometry. Uniform surface 
flux is assumed, as the reaction is kinetically limited within the current range investigated. 
Implicit in this description is the assumption that all of the current is consumed by the evolution 
of H2 (Equation 1) and that generated H2 adsorption to the surface is negligible (Macpherson 
and Unwin, 1997). 
The insulating parts of the array are described by 
 ∇𝐶 ∙ 𝑛 = 0 (5) 
and the exterior of the domain is taken to have zero concentration of H2, that is 
 𝐶 = 0 (6) 
The collector electrode potential is set such that the reverse reaction of Equation 1 
occurs at a diffusion-limited rate and is also described by Equation 6. The current at the 
collector, icoll, is an integral of the flux computed over the surface of the electrode, 
 𝑖𝑐𝑜𝑙𝑙 = 2𝐷 ∫ ∇𝐶 ∙ 𝑛 (7) 
where the 2 comes from the stoichiometry in Equation 1. 
To reduce the number of degrees of freedom we normalized the equations in time, 
length and concentration by making the following substitutions 
 𝑡 =
𝑇
𝜏
     where   𝜏 =  
𝑎2
𝐷
 (8) 
 𝑥 =  
𝑋
𝑎
; 𝑦 =  
𝑌
𝑎
; 𝑧 =  
𝑍
𝑎
 (9) 
 𝑐 = 𝐶/𝜒     where    𝜒 = −𝑖𝑔𝑒𝑛
𝑎
2𝐴𝐹𝐷
 (10) 
Where a is a characteristic length from the geometry, which in our case was taken to be the 
width of the collector electrode. This leads to the normalized version of Equation 2: 
 
𝜕𝑐
𝜕𝑡
= ∇2𝑐 − 𝑘𝑐 (11) 
with the normalized rate constant k defined as 
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 𝑘 = 𝜅𝜏 (12) 
and a modified set of boundary conditions 
    
∇𝑐∙𝑛= −1
∇𝑐∙𝑛= 0   
     ∀ 0 ≤𝑡 ≤ 𝑡
∗
   ∀ 𝑡<0 𝑎𝑛𝑑 𝑡 > 𝑡∗
 (13) 
 ∇𝑐 ∙ 𝑛 = 0 (14) 
 𝑐 = 0 (15) 
that are the normalized equivalents of Equations 3, 5, and 6 respectively, applying to the same 
boundaries in the transformed geometry, and t* = T*/τ . Note, ṉ is used here to represent the 
inward pointing unit normal in the transformed coordinates. 
The icoll in non-normalized coordinates is related to the normalized form, ĩcoll, by 
   
𝑖𝑐𝑜𝑙𝑙(𝑇) = 𝐷𝑎𝜒?̃?𝑐𝑜𝑙𝑙(𝑡)
?̃?𝑐𝑜𝑙𝑙(𝑡)= ∫ ∇𝑐(𝑡)∙𝑛
 (16) 
where the integration is taken over the electrode in the normalized coordinates.  
We made the useful observation that Equation 11 displays linearity; that is, if both c1(t) 
and c2(t) are linear then c3(t)= d1c1(t)+ d2c2(t) will also be linear for any values d1 and d2. This 
property arises from the first order clearance rate description and is not true for general 
clearance expressions. We also observe that Equation 11 is time invariant, meaning that 
another solution for any value of t0 is c4(t) = c1(t + t0). 
If we define c∞(t) as the solution for an infinitely long current pulse, initiated at t = 0, then 
we can derive the solution for a pulse of duration t*, also initiated at t = 0, is described by 
 𝑐𝑡∗(𝑡) =  𝑐∞(𝑡) −  𝑐∞(𝑡 − 𝑡
∗) (17) 
Equation 11 is satisfied by the linearity relation (d1 = 1, d2 = -1) and time invariance (t0 = t*). 
Boundary conditions 14 and 15 are trivially satisfied and 13 is satisfied by the summation of the 
fluxes, which cancel out for t > t*.  The current is similarly given by 
 𝑖?̃?𝑜𝑙𝑙,𝑡∗(𝑡) = 𝑖?̃?𝑜𝑙𝑙,∞(𝑡) − 𝑖?̃?𝑜𝑙𝑙,∞(𝑡 − 𝑡
∗)  (18) 
Where ĩcoll,t and ĩcoll,∞ represent the normalized collector current for a current pulse of duration t* 
and infinite length, respectively. Thus we can restrict ourselves to solving these equations for an 
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infinite pulse length, in practice until a (quasi) steady-state behavior is reached, for a range of 
geometries in the normalized space. 
 
Computational Details 
The solution to the equations was calculated using the commercial finite element 
modeling package COMSOL Multiphysics 4.3a (COMSOL AB) and was performed on the 
Biomedical Analysis and Simulation Supercomputer (BASS) at UNC Chapel Hill. The equations 
were discretized using a mesh which was chosen to be finest around the edge of the electrodes 
where flux is greatest. The mesh was determined to be sufficiently fine when further refinements 
did not perturb the solution. Similarly, the extent of the domain was made sufficiently large such 
that it did not affect the derived solution. 
 
Simulated Flow Rate Analysis 
Noise (0.02 – 0.4 nA) was added to simulated data at all flow rates, including 0 s-1, in the 
form of normally distributed, random numbers with a zero mean. This process was repeated 5 
times for each noise amplitude to determine the variation of the observed response. When 
performing analysis, data from 0 – 8 s was disregarded to exclude the generating pulse time 
and the first second of clearance and analyzed according to Stosseck et al (vide infra) 
(Stosseck et al., 1974). Statistical work was performed in GraphPad Prism 6 (GraphPad 
Software, San Diego, CA, USA). Student’s t-tests were used to determine significance, defined 
as P < 0.05. 
 
Results 
EHC arrays consisting of two individually addressable platinum electrodes were 
microfabricated (Figure 2.1A). The platinum is electrically insulated beneath silicon nitride, with 
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the exception of two pads at the top that connect to either the potentiostat or galvanostat, and a 
window at the tapered tip that exposes band electrodes where EHC is performed (Figure 2.1A, 
inset). The total probe width at the active electrode window is 100 µm, an order of magnitude 
smaller than existing EHC probes and more similar to existing microfabricated arrays used in 
vivo (Stosseck et al., 1974, Chen et al., 2009). The electrically insulated region between each 
electrode is approximately 5 µm wide. We used the two outer bands, each 100 x 20 µm, as the 
generator and the center electrode, 100 x 10 µm, as the collector. While exchanging the choice 
of the generator and collector would result in a higher overall collection efficiency (CE), defined 
as the percentage of the generator current measured at the collector electrode, the smaller 
generator area decreases the maximum current that could be applied and offers no signal 
enhancement. Higher current densities risk limiting the electrode lifespan or generating H2 
bubbles (Stosseck et al., 1974, Fernández et al., 2014). Of the isolated, diced devices from two 
separately processed wafers, 42 / 52 (80.8%) were functional, 6 / 52 (11.5%) were excluded 
(criteria for exclusion vide supra), and 4 / 52 (7.7%) could not have functionality assessed due 
to human error.  
 
Characterizing Platinum Arrays 
The one-electron reduction of RuHex (III) to RuHex (II) is an outer-sphere redox system 
with fast electron transfer kinetics that is ideal for characterizing microelectrodes. To validate 
that the electrodes had been correctly produced, cyclic voltammetry was performed at 5 mV s-1 
in degassed 2.5 mM RuHex (III) solutions to obtain steady state currents (iss). Background 
subtracted voltammogram currents show excellent agreement with simulation-calculated iss 
values (D = 9x10-6 cm2s-1, Figure 2.1B, dashed lines) (Macpherson et al., 1997). 
RuHex (III) reduction at the generator served as a model system to compare 
experimental clearance curves to those calculated. A current pulse (igen = -100 nA) reduced 
RuHex (III) to RuHex (II). This current is within the kinetically controlled current regime of a  
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Figure 2.1. Microfabricated platinum arrays are characterized by voltammetry and 
amperometry. (A) Model (to scale) of the full device shows two separately addressed, 100 μm 
long electrodes (inset: micrograph) selectively exposed at the tip. Inset color key: Purple is 
exposed silicon, green is silicon nitride, grey is insulated platinum beneath the nitride and white 
is bare platinum. (B) Cyclic voltammogram (5 mV s-1) in degassed solution containing 2.5 mM 
RuHex and 0.1 M KCl. Theoretical steady state currents, indicated as dashed lines, were used 
to confirm active electrode surface areas. (C) Clearance curves obtained from generating 
RuHex (II) (35 mM) in the period indicated by the grey bar, and collecting RuHex (III). Outer 
electrodes used -100 nA pulses to reduce RuHex (III). The inner electrode, held at +0.25 V, 
detects RuHex (II) oxidation as faradaic current. Experimental RuHex clearance shows 
excellent agreement with simulations of the same system. (D) The collection efficiencies, taken 
at the plateau current, significantly increases when all electrodes are electroplated in platinum 
black (Student's t-test: t(2,6) = 4.804, P = 0.003). 
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35 mM solution (iss = -578.5 nA at the generator) to eliminate the possibility of reducing other 
species (e.g. O2). The current at the collector, held at +0.25 V to re-oxidize Ru(II), shows  
excellent agreement with the response calculated from simulations matching the experimental 
conditions (Figure 2.1C).  
The theoretical response was calculated with varying pulse durations. Simulations 
determined that a 10 s generator current pulse was sufficient to reach locally saturated current 
with an expected 41.3% CE. Experimental results were in good agreement with CEs of 
37.4 ± 5.9% (t(2,4) = 1.478, P >0.05, Figure 2.1D). If greater CE were required, coating all 
electrodes with platinum black was shown to increase electroactive surface area significantly as 
compared to bare platinum, enhancing experimental CE to 54.8 ± 2.2% (t(2,6) = 4.804, P = 0.003) 
(Shin et al., 2008). 
 
Hydrogen Generation and Clearance 
EHC at bare platinum electrodes was first tested in an acidic solution, 0.5 M H2SO4, both 
because of its ability to clean platinum surfaces and for its availability of free protons. The 
electrodes were initially cycled between -0.5 and +1.0 V at 20 mV s-1 and verified as clean when 
the cyclic voltammograms at 20 V s-1 produced the classic peaks indicative of H2 and O2 
adsorption and desorption (Figure 2.2A). The pulse time necessary to achieve steady-state CE 
could be decreased to 7 s (Figure 2.2B), as H2 has a larger diffusion coefficient than RuHex.  
Table 2.1 summarizes CE values obtained from EHC experiments in various solutions. 
Solutions left open to air had 25.2 ± 3.0% CE (n = 5 devices, dashed line, Figure 2.2B), 
significantly poorer than theoretical predictions of 43.6% CE (t(2,4) = 13.71, P = 0.0001, n = 5). 
When the solution was degassed, the decrease in O2 was seen in the steady-state cyclic 
voltammograms as increased area beneath the H2 adsorption-desorption peaks and diminished 
area beneath those of O2 (Figure 2.2A). This is consistent with the idea that degassed solutions 
have less O2 capable of adsorbing to, and thus partially passivating, the active area of a bare 
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platinum surface (Bard et al., 1980). The clearance response in degassed acid closely matched 
that predicted by simulation (black line vs. gray line, Figure 2.2B) and achieved 34.6 ± 5.9% CE 
(t(2,3) = 3.05, P > 0.05, n = 4). Similarly, in solutions of aerated PBS, no collection current was 
obtained using igen = -100 nA, and igen = -700 nA pulse yielded only 0.49 ± 0.18% CE 
(t(2,3) = 479.0, P < 0.0001, n = 4). Once degassed, 30.4 ± 7.4% CE could be achieved in PBS 
using igen = -100 nA (t(2,2) = 3.09, P > 0.05, n = 3 devices). 
The decrease in CE is due to an O2-dependent competing reduction that consumes a 
large fraction of the generator current and produces one or more species that are undetectable 
amperometrically at +0.25 V. While this is problematic for in vitro studies in air-saturated 
solutions, O2 concentrations in the deep brain are approximately 5 times lower (~50 µM vs. 
~250 µM at pH 7.4, 25 °C (Robinson and Cooper, 1970)), thus it is expected that a majority of 
the current would go into producing H2 in vivo (Feng et al., 1988, Ndubuizu and LaManna, 
2007). It is important to note that the +0.25 V holding potential is sufficiently higher than the 
reduction potential of O2 itself, in addition to being lower than the oxidation potentials of common 
biological interferents (e.g. H2O2, ascorbic acid), ensuring that in vivo measurements will be 
insensitive to fluctuations in these analytes and specific for H2 (Aukland et al., 1964, Young, 
1980). 
Another operational problem in vitro was a decrease in CE with consecutive pulses 
(Figure 2.2C). Cycling the collector between pulses (20 V s-1, 2-4 s, -0.5 to +1.0 V) regained 
optimal CE and maintained reproducibility. We attribute this passivation to oxygen atom 
adsorption to the positively-polarized collector surface, which strips off with cycling (Sugawara 
et al., 2012). 
 
Modeled Flow 
Localized flow, termed microflow, can be determined from clearance curves following the 
procedures of Stosseck et al. (Stosseck et al., 1974). After reaching saturated values of H2 as  
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Table 2.1. EHC collection efficiencies measured at bare platinum microarrays. The center 
electrode served as the collector and two outer bands as generators. Collection efficiency 
reported at the end of a 7 s generation of H2. 
Solution Pulse Amplitude (nA) Collection Efficiency (%)a 
Modeled Prediction -100 43.6 
Aerated H2SO4 -100 25.2 ± 3.0*** 
Degassed H2SO4 -100 34.6 ± 5.9 
Aerated PBS 
-100 n/ab 
-700 0.49 ± 0.18**** 
Degassed PBS -100 30.4 ± 7.4 
aPresented as averages ± SD. Significance calculated using Student’s t-test and Welch’s 
correction against theoretical values: ***P < 0.001, ****P < 0.0001. 
bGenerating current used was insufficient to produce a collector response above baseline. 
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Figure 2.2. O2 reduction reactions compete with EHC in 0.5 M H2SO4 at bare Pt electrodes. (A) 
Steady-state cyclic voltammograms (inner electrode shown, 20 V s-1) indicate augmented H2-
adsorption peaks at a platinum surface in degassed acid versus air-saturated acid. In degassed 
solution, the decreased area beneath the O2 adsorption-desorption peaks also presents with a 
potential shift of the cathodic peak, indicative of fewer oxides present at the surface. (B) EHC 
curves in 0.5 M H2SO4 indicate that CE decreases in air-saturated solutions, but can be restored 
to theoretical levels after N2 bubbling. (C) Even EHC in degassed H2SO4 is subject to CE 
deterioration between subsequent pulses. Cycling the collector between pulses recovers CE 
(clearance curve indicated by dotted arrow) and ensures a maximized, consistent response. 
Generator pulses used were -100 nA. Collector potentials were held at +0.25 V. 
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assessed by a stable collection current plateau, galvanostatic generation ceases and H2 
clearance through diffusion and microflow begins. Note that, as total electroactive array area is  
100 µm x 60 µm and the average spacing between blood vessels is ~50 μm, clearance from a 
H2-saturated tissue volume will incorporate flow from multiple blood vessels (Klein et al., 1986).  
Previous works have shown that the clearance curve, the monoexponential current 
decay following the cessation of the generator pulse, provides a more reliable prediction of 
microflow than absolute current values achieved at saturation (Fellows and Boutelle, 1993). 
Current during clearance is expected to obey the following relation from Stosseck et al. 
 ln (
𝑖0
𝑖𝐹
) = 𝜅𝑇 + 𝑏  (19) 
where i0 (nA) and iF (nA) represent clearance currents in the absence and presence of flow, 
respectively, κ (s-1) is the microflow included in our model as a first-order rate (Equation 2), and 
b a constant deviation function (Stosseck et al., 1974). For convenience, we take T = 0 in 
Equation 19 to be the time when the generator pulse ends. Note, inhalation clearance 
experiments using millimeter-scale electrodes have reported polyexponential clearance rates 
because diffusion between grey and white matters differ, but our probe is small enough that we 
expect to avoid this issue (Fieschi et al., 1965).  
Modeled clearance data were analyzed according to Equation 19 and plotted as  
ln(i0/iF) vs. t (Figure 2.3A). The first second of clearance data was disregarded as the current 
ratio was constant, ~1, and contains no microflow information. The linear regressions were fit to 
the data from t  = 1-8 s (Figure 2.3A) to obtain κ values as slopes, making the time of one full 
CBF measurement total ~15 s and vastly improving temporal resolution compared to the 
multiple minutes per measurement seen in inhalation H2 clearance (Fellows and Boutelle, 1993, 
Lowry et al., 1997). Ideally, these slope values would match the microflow rates input into the 
simulations, but fitting the data during this time range overestimates the input rates by ~15%, 
seen as a deviation from unity of the slope comparing the input microflow rates to those 
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obtained from the slope fit (Figure 2.3B). This deviation highlights the importance of theoretical 
validation and indicates that the assumptions within Equation 19 are not strictly true, especially 
for shorter times (Stosseck et al., 1974). We conjecture that this deviation arises due to the 
strong concentration gradients between the two electrodes, which are an order of magnitude 
closer than those originally used (Stosseck et al., 1974). Fitting clearance data to longer time 
lengths decreases the magnitude of microflow overestimation, however it lowers temporal 
resolution. Since the relationship between the theoretically predicted and actual flows is linear, 
actual microflow can be calculated using a conversion factor obtained from simulations that 
match experimental parameters. This clearance protocol and analysis outline was optimized to 
establish balance between temporal resolution and flow rate accuracy for our specific geometry. 
Different protocols can be used with similar analysis to achieve desired metrics.  
As the ln ratio used in this simple EHC data analysis exaggerates current differences, 
one must also consider the magnitude of these differences and the impact of noise on their 
calculation. Randomly generated Gaussian noise was added to the simulated currents and the 
data were reanalyzed according to Equation 19 (Figure 2.3C). Simulations were calculated at 
~60 Hz to match experimental protocol. As expected, data analyzed with greater noise gave 
less reliable microflow values (Figure 2.3D). However, with experimentally achievable low noise 
levels (<0.05 nA in this case), calculated microflows show close agreement with expected 
values. The exact noise amplitude that ensures accuracy is a function of the array geometry and 
acquisition protocol (data not shown). In conclusion, finite element modeling faithfully 
reproduces the experimental phenomena and can be used to optimize and assess the suitability 
of novel geometries, quantify the robustness to noise, and calculate calibration factors.  
 
Detecting “Flow” with Microarrays 
A first-order chemical reaction was used as an in vitro model amenable to use with our 
arrays, as clearance currents exhibit first-order exponential decay (Stosseck et al., 1974). The 
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conversion of NE-orthoquinone, the oxidized product of NE, to its cyclized form, leuco-
noradrenochrome, was chosen, as the products are voltammetrically distinguishable and the 
reaction rate has been characterized. The rate of 0.98 ± 0.52 s-1 at pH 7.40 (Ciolkowski et al., 
1992) can be slowed by increasing the pH, necessary to better mimic the microflow rates 
expected for in vivo EHC (i.e. 0.005-0.030 s-1) (Sakurada et al., 1978).  
We initially assessed the cyclization rate at a range of pH values by stepping the 
potential at a polished glassy carbon electrode from -0.4 V to +0.5 V. The current-time response 
for each pH value was analyzed according to the time-dependent equation for an ECE process 
(Hawley and Feldberg, 1966).  The cyclization rates obtained were plotted against their 
corresponding pH values to verify the expected linear relationship (Figure 2.4A, R2 = 0.79). 
Calculated rates were between 0.37 s-1 at pH 8.13 and 0.70 s-1 at pH 7.40.  
Carbon pyrolyzed photoresist film (PPF) collector-generator arrays were used to monitor 
the cyclization rate because their surfaces can be stripped of the cyclized product, known to foul 
electrodes, by scanning to high voltages (Takmakov et al., 2010). Electrodes were assessed 
using cyclic voltammetry in solutions of 100 µM NE (Figure 2.4B). With 50 mV s-1 scan rates, NE 
is oxidized and reaches a diffusion-limited plateau at ~0.1 V. No reduction peak is observed on 
the reverse scan as there is sufficient time for the NE-orthoquinone to diffuse away. At 500 mV 
s-1, two reduction peaks are observed relating to NE-orthoquinone (Peak 1) and its cyclized form 
(leuco-noradrenochrome, Peak 2) (Hawley et al., 1967). 
For clearance measurements, generator electrodes oxidized NE (igen = +100 nA, 10 s) 
while the collector held 0.0 V; a potential sufficient to detect NE, but not the cyclized product 
(Figure 2.4B). In buffer, the collector current changes were negligible (-0.04 ± 0.02 nA), which 
confirmed collection currents as being solely NE-orthoquinone. The 50 mV s-1 voltammogram iss 
shows that the complete oxidation of NE to NE-orthoquinone will consume 2-3 nA, thus we are 
confident that the same diffusion-limited quantity is generated in all experiments. Voltage at the 
generator exceeded that required to completely oxidize NE in our solutions (Figure 2.4C). 
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Figure 2.3. Computer modeling predicted experimental inaccuracies in flow rate calculations 
from EHC data. (A) Simulated clearance curves for a range of physiologically expected flow 
rates were calculated and plotted following analysis with Equation 19. Time = 0 indicates the 
cessation of the generating pulse. The first second of clearance (shaded box) is excluded from 
the linear regression fit. (B) The linear fit slopes from plot A were compared to the actual rates 
used in the model. The calculated fits overestimated the true rate, but in a highly predictable 
manner amenable to correction. (C) The data from A with added Gaussian noise (0.02 nA). (D) 
Linear fits from C data with greater noise amplitudes can be less accurate at predicting the true 
microflow values. N = 4 replicates per noise value, per flow. Error bars ± SD. 
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In solutions within the pH range studied, a non-zero iss was achieved within 5 s (-0.54 ± 
0.05 nA, -0.74 ± 0.08 nA, -1.00 ± 0.13 nA, for pH 7.62, 7.83, 8.05, respectively), indicating that a 
portion of the oxidized product was not cyclized (Figure 2.4D). Higher collector currents at 
higher pH values are consistent with cyclization rates slowing under increasingly basic 
conditions. It is impossible to slow the reaction rate to zero to perform a ln(i0/iF) analysis, 
however, the current variability indicates that the array can sense reduced NE-orthoquinone 
before an intracyclization process that occurs at rates between 0.37 - 0.70 s-1. This experimental 
demonstration coupled with the previous theoretical results demonstrate the feasibility of 
measuring a wide range of microflow rates, including those expected for CBF. 
An important observation from these data is that the noise in the current collector is 0.02 
± 0.009 nA, below the 0.05 nA maximum noise for accurate determination of CBF (vide supra). 
This justifies the previously made assertion that we may use these devices to measure CBF. 
We conclude that our chosen geometry is capable of discerning microflow for rates at least as 
low as 0.005 s-1 and as high as 0.70 s-1, which is well above what is to be expected in vivo. 
 
Conclusions 
We report microfabricated EHC electrodes that are capable of detecting and reliably 
quantifying changes in CBF expected in vivo. Finite element modeling accurately reproduces 
the experimental current and allows us to calculate calibration factors, quantify the effect of 
noise, and choose optimized geometries and protocols. Microfabrication, which allows batch 
fabrication of implantable sensors in reproducible yields of >80%, enables EHC arrays to be a 
more affordable alternative to existing CBF detection techniques. These devices have high 
temporal and spatial resolution, and implanting an electrode ensures its insensitivity to subject 
motion. These advantages over both traditional EHC sensors and other CBF measuring 
techniques importantly present opportunities for future experiments where in vivo CBF 
quantification can take place in freely-moving subjects beneath the cortex. 
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Figure 2.4. The intracyclization rate of NE-orthoquinone modeled a first order reaction decay in 
lieu of perfusion flow experiments. (A) The rate of the reaction was determined in solutions of 
varying pH using potential-step amperometry at a glassy carbon disk electrode (n = 4 
replicates). (B) Cyclic voltammetry performed in 100 μM NE solutions was used to select a 
collector potential, VCollector = 0.0 V, to detect Peak 1, NE, and exclude faradaic currents from 
Peak 2, leuco-noradrenochrome. (C) Representative voltage vs. time traces at the generator 
electrode producing a 10 s, +100 nA pulse. NE oxidation significantly raised the voltages 
necessary to produce a generating pulse against buffer alone (1.59 ± 0.002 from 1.45 ± 0.01 V, 
t(2,4) = 9.262, P = 0.0008). (D) Representative current vs. time plots with the collector held at 0.0 
V during a 10 s, +100 nA pulse. In solutions with NE, the collector was capable of detecting 
Peak 1 from B across all pH values tested (n = 11 replicates). Grey bars indicate pulse time. 
Error bars indicate ± SD. 
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CHAPTER 3: OPTIMIZING THE DESIGN AND FABRICATION OF MICROFABRICATED 
HYDROGEN CLEARANCE SENSOR FOR IN VIVO USE 
 
Introduction 
Cerebral blood flow (CBF) is a tightly regulated physiological process that replenishes 
glucose and oxygen (O2) concentrations to brain tissue following neuronal activity. Glucose and 
O2 are the key metabolic substrates consumed to maintain ion gradients in the brain, and when 
CBF becomes dysregulated, the collapse of these gradients can lead to cell death (Dirnagl et 
al., 1999, Zauner et al., 2002, Harris et al., 2012). To date, most CBF studies have been 
conducted in cortical locations, where optical techniques, such as laser Doppler flowmetry 
(Dirnagl et al., 1989) and two-photon microscopy (Helmchen et al., 2001), can obtain accurate 
and precise CBF measurements. However, both neuronal and vascular differences exist 
between the cortex and deeper brain regions (Iadecola and Nedergaard, 2007).  To investigate 
CBF in subcortical regions, researchers have turned to either expensive magnetic resonance 
imaging (Calamante et al., 1999) or clearance techniques (Lacombe et al., 1980). Existing 
clearance methods are limited in that they either rely on highly-invasive electrodes, or are 
dependent upon a finite availability of unique fluorophores or radiolabels (Lacombe et al., 1980, 
Prinzen and Bassingthwaighte, 2000). To address these technical challenges and permit further 
subcortical CBF studies, we have sought to improve upon an existing clearance technique.  
Hydrogen clearance is a well-established gas clearance method used to quantify CBF 
that correlates well with other accepted CBF-measuring techniques (Aukland et al., 1964, 
Young, 1980, Larsen et al., 2008). This method introduces inert H2 into a biological system until 
it reaches a saturated level in the area of interest. The supply of H2 is then ceased, and 
subsequent clearance of the gas is then measured through amperometric H2 oxidation at a 
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polarized electrode.   The current generated by H2 oxidation decays exponentially as H2 clears 
the tissue via diffusion and blood flow, and can be used to calculate CBF (Aukland et al., 1964). 
In situ electrolytic H2 clearance (EHC) is the fastest of the H2 clearance methods, and requires a 
platinum electrode array (Aukland et al., 1964, Stosseck et al., 1974, Young, 1980, Larsen et 
al., 2008). In EHC, a galvanostatic pulse from a generator electrode produces H2, which is 
sensed at the second collector electrode (Stosseck et al., 1974). This electrochemical time-of-
flight technique has been used in both animals and human studies, but the electrode sizes have 
historically limited brain applications (Koshu et al., 1982, Shima et al., 1985, DiResta et al., 
1987, Kawasuji et al., 1988), as existing EHC sensors exceed a millimeter in diameter 
(Stosseck et al., 1974, DiResta et al., 1987). To limit tissue damage, smaller arrays are needed 
to perform EHC measurements in subcortical regions. 
Recently, we miniaturized EHC arrays to a micron-scale using microlithography to both 
minimize tissue damage and improve spatial and temporal resolution for sub-cortical blood flow 
measurements (Walton et al., 2016). However, the accuracy of our previous approach relied on 
noise levels ≤50 pA. Though our in vitro measurements routinely had background noise of 
~20 pA, greater noise levels are expected in vivo.  Here, we take further advantage of 
computational modeling to optimize device geometries for both improving collection efficiencies 
(CEs), defined as the percent of generated H2 that is oxidized and thereby sensed at the 
collector(s), and expanding the range of experimental background noises under which the 
devices can operate. Following the improved design of our arrays, we modified the 
microfabrication process to yield devices sufficiently thin to be used in vivo, as opposed to the 
thicker, diced prototype devices of our previous work (Walton et al., 2016). Together, these 
improvements will better serve the intended use of measuring localized CBF changes in 
subcortical brain regions.  
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Experimental 
Chemicals and Solutions 
 KOH was obtained from Fisher Scientific (Pittsburgh, PA) and its solutions were made 
fresh immediately prior to wet etches. AZ1518 positive tone photoresist was obtained from AZ 
Electric Materials (Branchburg, NJ) and NFR 016 D2 negative tone photoresist was from JSR 
Corp. (Tokyo, Japan). All other photolithographic chemicals were purchased from Shipley 
(Marlborough, MA) unless otherwise noted. 
 
Platinum Electrode Array Fabrication 
Platinum EHC arrays were fabricated, in a process similar to previously-reported arrays 
(Walton et al., 2016), using instruments at both the North Carolina State University 
Nanofabrication Facility (NNF) and the Chapel Hill Analytical and Nanofabrication Laboratory 
(CHANL) at UNC Chapel Hill. All uses of photoresist were preceded by a dynamic 
acetone-methanol-isopropyl alcohol clean followed by dynamic application of 
hexamethyldisilazane (HMDS) as an adhesion promoter.  
Backside. Silicon wafers (University Wafer, Inc., Boston MA), 200 µm thick, were 
insulated with silicon nitride (3400 Å) using low-pressure chemical vapor deposition (LPCVD). 
Photolithography began on the backside of the wafer. First, AZ1518 positive photoresist was 
spun on the wafer at 2750 rpm for 60 s and soft-baked at 95 °C for 60 s. The wafers were 
exposed to ultraviolet (UV) light for 4.8 s at a mask aligner (Karl Suss MA6), developed in 
MF319, and then hard-baked at 115 °C for 5 min. Reactive ion etching (RIE) was used to etch 
the backside nitride through to the silicon.  
Level 1. The front of the wafer was spun with a negative photoresist (NFR 016 D2) at 
3000 rpm for 40 s, followed by a 60 s soft-bake at 95 °C. After the Level 1 mask was aligned to 
the backside etches, the patterns were exposed to UV light for 3.5 s and baked at 95 °C for an 
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additional 90 s. After the wafers were developed, the nitride was dry-etched with RIE to pattern 
trenches of approximately 600 Å. Titanium metal was evaporated over the entire wafer (200 Å) 
to aid adhesion between the LPCVD nitride and subsequently evaporated platinum (400 Å). Lift-
off was achieved with acetone, followed by a standard RCA-1 clean. Level 1 geometries were 
insulated with silicon nitride (15 kÅ) using plasma-enhanced chemical vapor deposition 
(PECVD). 
Level 2. Photolithography using HMDS followed by S1813 positive photoresist isolated 
areas of electrical exposure on the front side of the wafer. Approximately half (6.5 kÅ) of the 
PECVD nitride was dry-etched through, leaving the other half to protect the front devices. 
Approximately 160 µm of silicon was wet-etched from the backside of the wafer in a solution of 
30% KOH by weight, heated to 70-80 °C. 
Level 3. S1813 positive resist was spun on the front side of the etched wafer at 
2000 rpm for 60 s, soft-baked at 115 °C for 60 s, aligned to the Level 3 mask, UV-exposed for 
12 s, developed in MF319, and finally hard-baked at 115 °C for an additional 5 min. The 
remainder of the PECVD and LPCVD nitrides was RIE etched through using the Level 3 pattern, 
the residual photoresist of which was plasma cleaned off prior to the releasing KOH step. 
Release. The remaining 40 µm of silicon were wet-etched in hot KOH from both 
front- and backsides of the wafer until the silicon surrounding the devices was fully etched away, 
leaving devices to be removed manually from patterned “bridges” with a scalpel and tweezers 
(Figure 3.1A-B). Each wafer totaled 72 individual devices with one of the following four array 
dimensions described in Table 3.1: 20 of Device B, 21 of Device D, 14 of Device E, and 17 of 
Device F.  
 
Modeling 
EHC operates on the basis of applying a cathodic current igen, sufficient to reduce 
endogenous H+, at a generator electrode to produce a discrete bolus of H2 (Equation 1).   
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Table 3.1. Modeled geometries for platinum EHC microarrays. Inter-electrode spacing refers to 
the space between the central generator and each of the two collector electrodes. 
Device 
Generator 
Length (µm) 
Generator 
Width (µm) 
Collector 
Length (µm) 
Collector 
Width (µm) 
Inter-Electrode 
Spacing (µm) 
A 
100 
20 
100 
30 10 
B 20 30 25 
C 
200 
20 
200 
30 25 
D 20 30 35 
E 30 30 25 
F 50 25 25 
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Elsewise, the generator is held at 0 V to neither produce additional H2, consume H+, nor 
electrochemically affect other biological analytes (Young, 1980). The collector is held at +0.25 V 
throughout the duration of the experiments to amperometrically oxidize the H2 delivered by 
diffusion and flow. 
 2 𝐻+ + 2 𝑒−  →  𝐻2 (1) 
We used finite element modeling to calculate the H2 concentrations as they varied 
spatially over time, as previously reported (Walton et al., 2016). Briefly, mass transport was 
modeled using a three-dimensional solution of the reaction-diffusion Equation 2, where C is the 
H2 concentration,  D = 5x10-5 cm2s-1 its diffusion coefficient (Macpherson and Unwin, 1997), T 
the time (s), and κ (s-1) the first order rate constant for H2 clearance, as proposed by Stosseck et 
al. (Stosseck et al., 1974, Young, 1980). 
 
𝜕𝐶
𝜕𝑇
= 𝐷∇2𝐶 − 𝜅𝐶 (2) 
The generator electrode is bound by the following initial condition 
 𝐷∇𝐶 ∙ 𝑛 =  
𝑖𝑔𝑒𝑛(𝑇)
2𝐴𝐹
 (3) 
where 
 𝑖𝑔𝑒𝑛(𝑇) =  |
𝑖𝑔𝑒𝑛
0   
  ∀ 0≤ 𝑇 ≤ 𝑇
∗
 ∀ 𝑇<0 𝑎𝑛𝑑 𝑇 > 𝑇∗
 (4) 
In these equations, ṉ is the inward pointing unit normal, F is Faraday’s constant, A is the 
generator electrode area, and 2 is from Equation 1 stoichiometry. Meanwhile, the concentration 
of H2 at the collector is set to zero, as we assume that the reduction of H2 at the applied 
potential is diffusion limited. This current, icoll, is obtained by integrating the flux normal to the 
electrode surface as follows, taking into account the 2 from Equation 1 stoichiometry. 
 𝑖𝑐𝑜𝑙𝑙 = 2𝐷 ∫ ∇𝐶 ∙ 𝑛 (5) 
All data were normalized, and discrete pulses were modeled utilizing linear algebraic 
relationships shown in Equation 6, where ĩcoll,t and ĩcoll,∞ represent the normalized collector 
current for a current pulse of duration T* and infinite length, respectively. We used T* = 8 s. 
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 𝑖?̃?𝑜𝑙𝑙,𝑡∗(𝑡) = 𝑖?̃?𝑜𝑙𝑙,∞(𝑡) − 𝑖?̃?𝑜𝑙𝑙,∞(𝑡 − 𝑡
∗)  (6) 
 
Computational Details 
The solution to the equations was calculated using the commercial finite element 
modeling package COMSOL Multiphysics 4.3a (COMSOL AB) and was performed on the 
Biomedical Analysis and Simulation Supercomputer (BASS) at UNC Chapel Hill. The domain 
over which calculations took place extended an order of magnitude past expected diffusion 
limits, such that it did not affect solutions at the electrode surfaces. A mesh was used to 
discretize solutions, and was made finest at the electrode edges where flux was greatest. 
Elsewhere, meshes were coarser to minimize simulation times while maintaining accuracy. 
Meshes were optimized to the point where further refinements did not alter solutions.  
 
Calculating Noise Tolerance for Accurate Flow Analysis 
Flow rates were calculated as described in detail previously (Walton et al., 2016), 
according to the following relation 
 ln (
𝑖0
𝑖𝐹
) = 𝜅𝑇 + 𝑏  (7) 
where i0 (nA) and iF (nA) represent clearance currents in the absence and presence of flow, 
respectively, κ (s-1) is the microflow, and b is a constant deviation function (Stosseck et al., 
1974). Briefly, modeled clearance data were plotted as ln(i0/iF) vs. T, excluding the first second 
of clearance data. With T=0 in Equation 7 defined as the end of the generator pulse current, 
post-pulse data T = 1-8 s were fit with linear regressions to obtain slope values, κ, that 
overestimated flow in a calculable, correctable manner dependent upon the array geometry. 
Fitting clearance data to longer time lengths decreased the magnitude of this microflow 
overestimation, but at the expense of temporal resolution. 
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Noise (0.02 – 0.4 nA) was added to simulated data at all flow rates, including 0 s-1, in the 
form of normally distributed, random numbers with a zero mean. This process was repeated 5 
times for each noise amplitude to simulate a variety of random environmental noise. The flow 
rates used in the modeling and the slopes obtained from the analyzed data were plotted on the 
abscissa and ordinate, respectively, and fit to a linear regression. The stronger the linear fit, the 
more reliable the accuracy of a CBF measurement under different experimental noise 
amplitudes.  
 
Results and Discussion 
We fabricated released devices in four different geometries (Figure 3.1A-B), each 
approximately 10 mm in length. The three EHC electrodes forming our array were located at the 
probe tip and exposed through a window in electrically-insulating silicon nitride. The dimensions 
of these geometries were chosen based on computer modeling where the central electrode was 
designated as the generator and the two adjacent electrodes to either side, being electrically 
connected, served as a single collector (Figure 3.1C). The average spacing between blood 
vessels is approximately 50 μm, and the electroactive array areas used here range from 
20 x 100 µm to 50 x 200 µm, ensuring that the tissue affected by EHC will average flow values 
obtained from multiple blood vessels (Klein et al., 1986). The average thickness of these 
devices was 210 ± 24 µm at the base (n=6) and 15 ± 6 µm at the tip (n=4), compared to the 
uniform 450 ± 36 µm (n=9) of the diced devices published previously (Walton et al., 2016). We 
know from previous work (Walton et al., 2016) that utilizing a three-electrode array geometry 
maximizes collection efficiency when the central electrode is used as the generator and the 
adjacent electrodes serve as collectors. Data were modeled using this convention.  
Optimizing our sensor geometry focused on mostly maximizing both the tolerated noise 
level and collection currents, while limiting the overall size of the electrode areas to 
physiologically reasonable dimensions. Tolerated noise refers to the amount of random 
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Figure 3.1. Platinum hydrogen clearance arrays were microfabricated in a modified workflow to 
produce devices thin enough for in vivo use with optimized dimensions. (A) A photograph of a 
wafer fragment shows how individual probes anchor to the wafer scaffold throughout the 
fabrication process through silicon “bridges” at their base (left). Bridges were broken to release 
the probes (right). (B) Optical image of a fully-released probe compared to a United States 
dime. Both the thickness and width tapered to a fine tip. (C) Expanded representations, to scale, 
of the four different array geometries fabricated in this work. The central platinum electrode was 
modeled as the generator, while the two electrodes to either side jointly served as a collector 
electrode. Letters in italics correspond to the devices in Table 3.1. Green represents PECVD 
silicon nitride, purple is exposed LPCVD silicon nitride, and white is bare platinum. 
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environmental noise that the sensor can be subjected to and still linearly correlate to actual CBF 
values used to model collector current, as described previously in detail (Walton et al., 2016). 
Briefly, clearance data were plotted according to Equation 7 for multiple, physiologically-relevant 
flow rates (0.005-0.03 s-1). Flow rates were obtained from fitting these data to linear regressions, 
then plotted against the modeled ideal flow rates. Each geometry slightly overestimates the true 
flow value used to calculate clearance data, necessitating that this be done first in the absence 
of any environmental noise to obtain the device’s flow correction factor (Walton et al., 2016). We 
artificially introduced random noise to the theoretical data and performed the analysis again to 
gauge the accuracy of the linear fits for a given noise amplitude. For the purposes of this study, 
we defined maximum tolerated noise to be the highest artificially-added noise amplitude that, 
when fit to a linear regression against true flow values, results in an R2≥0.99.  
We modeled a variety of electrode geometries, summarized in Table 3.1. The collection 
efficiencies between the modeled devices were within 20% of one another (Figure 3.2A), though 
the fabricated devices (Devices B, D-F, Table 3.1) were within 10% of one another. The 
maximum tolerated noise thresholds for the devices varied from 23 – 180 pA (Figure 3.2B). 
Overall, the best balance struck between CE, total electrode width, and ability to more 
accurately quantify CBF came from modeling Device E. 
We modeled Device A to resemble our previous device (Walton et al., 2016), using small 
electrode surface areas and narrow inter-electrode spacing, that is, the spacing between the 
generator and each collector electrode (Table 3.1).  Models of this geometry had 72.0% CE and 
a 23 pA noise limit (Figure 3.2). The latter metric led us to omit this geometry from fabrication, 
as it approached the 20 pA background noise levels of our instrumentation. To investigate the 
effect of inter-electrode spacing, we increased this variable from 10 to 25 µm (Device B, Table 
3.1). This decreased CE but roughly doubled the maximum tolerated noise limit (56.2% and 
42 pA, respectively, Figure 3.2). To see if further increasing inter-electrode spacing would 
improve the tolerated noise limit more, we modeled a device with 35 µm inter-electrode spacing 
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Figure 3.2. Optimizing device geometries affected both the collection efficiency and the 
tolerated electrical noise of hydrogen clearance microarrays. (A) Collection efficiency is defined 
as the combined, maximum collection efficiency from both collector electrodes during an 8 s 
modeled H2 pulse (i.e., not fully steady-state) under conditions of no additional flow. The values 
with physiologically-relevant flow rates present (up to 0.030 s-1) were still within 1% of these 
maximum values for all geometries. (B) Maximum tolerated noise is defined as the highest 
amplitude of background noise where a linear fit of experimentally-modeled data to true flow 
values is in agreement such that R2≥0.99, to provide confidence in the accuracy of obtained 
measurements. 
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(Device D, Table 3.1). This substantially improved noise limitations as predicted, with a modest 
decrease in CE (150 pA and 57.8%, respectively, Figure 3.2). Thus, inter-electrode spacing 
greatly impacted the maximum tolerated noise limit of our EHC arrays.  
Collection current can be simplified from Equation 5 as being the product of flux (𝐽), 
Faraday’s constant (𝐹), and the number of electrons involved (e- = 2 for H2 oxidation). As the 
latter two are constants, it became advantageous to maximize the flux integrated across the 
collectors, most easily achieved through increasing the electrode surface area. We investigated 
whether CE improved with greater surface areas. Devices B-C kept the same generator-to-
collector surface area ratio (1:3), but the total surface area of Device B electrodes was half that 
of Device C electrodes. As such, the CE of Device B (56.2%, Figure 3.2A) was inferior to that of 
Device C (64.6%, Figure 3.2A) and the tolerated noise threshold rose slightly (42 to 38 pA from 
Device B and C, respectively, Figure 3.2B). Interestingly, Devices A-D had 1:3 ratios of 
generator-to-collector surface area ratios, but CEs for these devices ranged from 56.2 to 72.0% 
(Figure 3.2A) and tolerated noise from 23 to 150 pA (Figure 3.2B). Thus, both the absolute and 
relative electrode dimensions contribute to CE and maximum tolerated noise.  
To change the surface area ratios while keeping the inter-electrode spacing consistent 
between models had detrimental effects on both explored metrics. The respective generator-to-
collector surface area ratios for Device E and Device F were 1:2 and 1:1, with the same inter-
electrode spacing, but Device E both had superior CE and tolerated more noise than Device F 
(61.6% versus 54.6% and 180 versus 63 pA, respectively, Table 3.1). With spacing kept 
constant, this contradicted the idea that larger generators would improve CE and suggested that 
the ratio of electrode surface areas has influence on both CE and tolerated noise. 
Using the central electrode as a generator instead of the larger combined surface area 
of the two outer electrodes, as was done in our previous work (Walton et al., 2016), runs the risk 
of generating potentially-disruptive H2 microbubbles with sufficient current densities applied 
(Fernández et al., 2014). We increased the surface areas of the central generator electrode to 
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provide more of a buffer against this risk. Device D was therefore compared to a device model 
that duplicated its dimensions with the exception of having a wider generator (Device E, Table 
3.1). Both the CE and the maximum tolerated noise improved (57.8% to 61.6% and 150 to 180 
pA from Device D to E, Table 3.1, Figure 3.2) with a wider generator dimension, though the 
inter-electrode spacing was decreased to compensate for the additional width and may have 
contributed to these effects. Device F further increased the generator width (and decreased the 
collector widths to compensate), yet this had detrimental effects on both CE and noise 
limitations (61.6% to 54.6% and 180 to 63 pA from Device E to F, Table 3.1, Figure 3.2). We 
concluded that, while a larger generator may reduce the risk of generating microbubbles, the 
relative size of the collectors and the spacing between the electrodes must adjust accordingly to 
maintain optimal CE and noise tolerance. 
The maximum tolerated noise was greatly affected by both changing the inter-electrode 
spacing and modifying electrode surface areas between two sets of otherwise identical devices. 
Devices C and D had matching electrode surface areas, but the 10 µm wider inter-electrode 
spacing of Device D produced a nearly 4-fold difference between their maximum tolerated noise 
thresholds (180 versus 63 pA for Device C and D, respectively, Table 3.1). Meanwhile, Devices 
C and E were identical save for a 10 µm difference in generator widths. Device E, with the 
greater generator surface area, had nearly a 5-fold improvement in the maximum tolerated 
noise as compared to Device C (180 versus 38 pA, respectively, Table 3.1) with negligible 
effects on CE (61.6% versus 64.6%, respectively, Table 3.1). Future work is needed to fully 
investigate these relationships at a quantitative level.  
 
Future Directions 
 Through a series of progressive geometry manipulations, we were able to customize 
electrode arrays using computational modeling to improve desirable qualities such as greater 
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CE or confidence in measurements taken in electrically-noisy environments. Further modeling 
could be used to explore more deeply the relationships between these metrics and device 
dimensions, or to tailor a device to cover larger tissue areas. The devices have been fabricated 
and released successfully, but require further testing to determine whether the electrodes are 
functional and agree with theoretical modeling as closely as previous devices (Walton et al., 
2016). 
Ultimately, these devices will be used to explore CBF changes in vivo. To reliably 
position these devices perpendicular to the brain’s surface will require mounting the devices to a 
circuit board, as performed previously (Zachek et al., 2010). The 10 mm length of the device 
enables exploration throughout the entirety of the rat brain. The tapered thickness, which starts 
from approximately 15 µm at the tip to over 200 µm at the base where the electrical connections 
are made, will generate minimal tissue damage compared to existing EHC devices (Stosseck et 
al., 1974, DiResta et al., 1987). To confirm the utility of these devices in monitoring CBF, future 
work should investigate scenarios where CBF changes are reliably provoked, such as 
measurements in the cortex following whisker stimulation or cortical spreading depression 
(Dunn et al., 2001, Wang et al., 2003). 
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CHAPTER 4: CHEMICALLY SELECTIVE, LOCAL GLUTAMATE STIMULATION USING 
IONTOPHORESIS 
 
Introduction 
Despite accounting for a small portion of total body mass, the brain uses a 
disproportionately large percentage of the body’s resting energy. This discrepancy arises from 
the energetically expensive demands of neuronal communication and the maintenance of ionic 
gradients (Sokoloff, 1989).  Metabolic substrates in the form of glucose and O2 are replenished 
after neuronal activity via increased regional cerebral blood flow (CBF), where they are 
consumed to generate adenosine triphosphate (ATP) and reestablish ion gradients. To maintain 
energetic homeostasis, neuronal activity is typically coupled with increased CBF in a process 
termed functional hyperemia (Roy and Sherrington, 1890). However, when neuronal activity and 
CBF decouple, blood flow cannot replenish the energy consumed during neurotransmission. 
Energy deficits result in the collapse of ionic gradients, and often lead to neuronal death (Drake 
and Iadecola, 2007). CBF increases are not exclusively controlled by metabolic deficiencies 
however, as CBF changes in response to a task are unaltered by induced hypoglycemia and 
hypoxia (Powers et al., 1996, Mintun et al., 2000).  Further, although CBF delivers excess O2 to 
overcompensate for energy loss, the concentrations delivered vary depending on stimulus type 
and intensity (Nielsen and Lauritzen, 2001, Thompson et al., 2003, Offenhauser et al., 2005). 
Together, these suggest that neuronal activity and metabolic deficits play complex roles in the 
regulation of energy throughout the brain.  
CBF is often measured by monitoring extracellular O2 concentrations, where increases in 
O2 can be attributed to increases in blood flow. This is the basis for blood oxygenation level-
dependent (BOLD) functional magnetic resonance imaging (fMRI) (Ogawa et al., 1990); 
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however, positive BOLD fMRI signals (i.e., increases in oxygenated blood) only infer the 
presence of increased neural activity (Hillman, 2014). Fast-scan cyclic voltammetry (FSCV) is 
also used to measure O2 concentration changes at high spatial resolution (Zimmerman and 
Wightman, 1991, Bucher et al., 2014), but electrochemical measurements offer no information 
about neuronal activity. Previously, we used a multimodal sensor to perform simultaneous 
voltammetric and single-unit electrophysiology measurements (Takmakov et al., 2011). Here, 
we expand the capabilities of our sensor to study both O2 dynamics in conjunction with cell 
firing.  This approach uses a single, minimally invasive carbon fiber microelectrode, and enables 
simultaneous detection of both neuronal activity and oxygen consumption in localized 
environments.  Further, we coupled iontophoresis, a local drug delivery method, to FSCV and 
electrophysiology to form a comprehensive suite of techniques to study functional hyperemia. 
Through iontophoresis, we locally stimulated neurons by ejecting glutamate, an excitatory 
neurotransmitter (Krnjević and Phillis, 1963, Lamour et al., 1988, Nicola et al., 2000). Together, 
this multimodal method allowed us to investigate the link between glutamate-elicited neuronal 
excitation and coupled O2 responses in localized microdomains. 
In this study, we compared the effects of electrically stimulated glutamate versus local 
glutamate iontophoresis on O2 dynamics between the dorsal striatum and somatosensory 
cortex. We first elicited endogenous glutamate release via electrically stimulating the prefrontal 
cortex (PFC), and found that striatal O2 concentrations both increased and decreased in a 
manner dependent on stimulation intensity and the availability of ionotropic glutamate receptors 
(iGluRs).  In contrast, glutamate iontophoresis in the striatum either responded with O2 
decreases or were unresponsive to glutamate. Finally, we compared the effects of 
locally-ejected glutamate on O2 concentrations and cell firing between cortical and striatal 
locations. The majority of recording locations responded to glutamate iontophoresis with 
increased cell firing and subsequent O2 decreases. Together, these data show that O2 responds 
differently to electrically evoked glutamate release than to targeted, chemically-specific 
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glutamatergic excitation, and that neuronal firing does not always couple to O2 throughout the 
cortex and striatum. 
 
Experimental 
Animal Care 
All animal protocols were approved by the Institutional Animal Care and Use Committee 
of the University of North Carolina at Chapel Hill (UNC). Male Sprague-Dawley rats (300-450 g, 
Charles River, Wilmington, MA, USA) were pair-housed at UNC animal facilities, given food and 
water ad libitum, and kept on a 12 hour light/dark cycle. Care was taken to reduce the number 
of animals used and minimize their suffering. A total of 6 animals were used for stimulation 
experiments, and data were pooled and analyzed from 70 animals originally used for other 
protocols. 
 
Surgery 
Animals were anesthetized with urethane (1.5 g/kg i.p.) and placed in a stereotaxic 
frame (Kopf, Tujunga, CA, USA). Holes were drilled in the dorsal striatum (+0.7 or +2.0 mm A-P, 
+3.2 mm M-L, -2.5 to -3.5 mm D-V) for the carbon-fiber electrode, and the PFC (+3.0 mm A-P, 
+0.8 mm  M-L, -3.0 mm D-V) for the stimulating electrode. Coordinates are relative to bregma 
from the Paxinos and Watson (2007) atlas. Depths were from dura mater. A Ag/AgCl reference 
electrode wire was placed in the contralateral hemisphere and served as an iontophoresis 
ground. Holes were drilled for glutamate iontophoresis studies in the striatum (+2.2 mm A-P, 
+1.7 mm M-L, -6.4 to -7.8 mm D-V) and somatosensory cortex (+0.6 mm A-P, +2.8 mm M-L and 
+2.0 mm A-P, +2.6 mm M-L, -0.9 to -2.0 mm D-V for each). 
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Drugs and Solutions 
DL-2-amino-5-phosphonopentanoic acid sodium salt (AP5, NMDA receptor antagonist), 
and 1,2,3,4-Tetrahydro-7-nitro-2,3-dioxoquinoxaline-6-carbonitrile disodium salt (CNQX, AMPA 
receptor/kainate antagonist) were obtained from Abcam (Cambridge, MA, USA). All other 
chemicals were obtained from Sigma Aldrich (St. Louis, MO, USA). Drugs were dissolved in 
5 mM NaCl and ejected iontophoretically using cathodic currents (-25 to -400 nA).  
 
Voltammetric O2 Measurements and Iontophoresis 
Mutimodal sensors were fabricated as described previously from four-barrelled glass 
capillaries (Belle et al., 2013). Briefly, a ~5 µm diameter carbon fiber, pulled into a glass 
capillary, was inserted into a 4-barrel capillary and cut under a light microscope to an exposed 
length between 80 - 120 µm. The remaining barrels were filled with drug solutions. 
Fast-scan cyclic voltammetry (FSCV) measurements were obtained and analyzed with a 
High-Definition Cyclic Voltammetry (HDCV) computer program (Bucher et al., 2014). The cyclic 
voltammetric waveform was 11 ms in duration, first scanned from a holding potential of 0.0 V to 
+0.8 V, then to -1.4 V, and finally back to the holding potential (vs. Ag/AgCl reference electrode) 
at a scan rate of 400 V s-1. Carbon-fiber surfaces were conditioned in the brain by scanning the 
waveform at 60 Hz, followed by 10 Hz, each for 15 minutes. A repetition rate of 5 Hz was used 
for simultaneous electrochemical and elecrophysiological measurements as described 
previously (Takmakov et al., 2011). Locally-designed instrumentation controlled the connection 
of the carbon fiber alternately to a current transducer (for cyclic voltammetry) and a voltage 
follower (electrophysiology measurements) (Takmakov et al., 2011). 
Iontophoretic ejections were performed by applying constant current (NeuroPhore BH-2 
System, Harvard Apparatus, Holliston, MA, USA). Ejection timing was controlled by HDCV. 
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Iontophoretic barrels were primed at least 400 µm dorsal to the measurement region to ensure 
reproducible ejections.  
 
Single-Unit Activity Electrophysiology 
Single-unit activity was measured for 179 ms between each cyclic voltammetric scan.  
The data were amplified (x5,000), fed through a bandpass filter (300 – 3,000 Hz, Krohn-Hite 
Corp., Brockton, MA), and digitized using commercially-available software (Digitizer, Plexon, 
Dallas, TX, USA). 
 
Electrically-Stimulated, Endogenous Glutamate Release 
Two optically-isolated stimulators (NL, 800 A, Neurolog, Digitimer, Hertfordshire, UK) 
were used to generate electrical stimulations at a bipolar stainless steel electrode (Plastics One, 
West Lafayette, IN, USA) in the PFC glutamatergic cell bodies. A multimodal sensor was placed 
in the ipsilateral dorsal striatum. One drug barrel contained glutamate (200 mM) (Lamour et al., 
1988), while another contained an AP5 (50 mM) and CNQX (10 mM) cocktail to antagonize 
iGluRs. Recordings were taken at locations where cells were present, defined as locations 
where single-unit activity accompanied a 2 s glutamate ejection using currents <-100 nA. The 
electrode depth was optimized for the strongest biphasic response while maintaining sensitivity 
to iontophoresed glutamate. One location was used per animal. 
First, baseline files were collected without stimulation. Then, stimulations were optimized 
for biphasic O2 responses while maintaining physiologically-relevant stimulus lengths. 
Stimulation frequencies from 5 to 60 Hz; all stimulations were comprised of 120 biphasic pulses 
of 0.2 ms width and 300 µA amplitude. To measure the effect of stimulation duration, we held 
stimulation frequency and current amplitude constant (20 Hz and 300 µA, respectively) and 
varied pulse numbers from 10-100.  
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Pharmacological studies investigated the role of local iGluRs on O2 events in the 
striatum following PFC stimulation. A drug cocktail (50 mM AP5 and 10 mM CNQX) to 
antagonize NMDA, AMPA, and kainate receptors iontophoretically ejected into the dorsal 
striatum recording location for 60 s using cathodic current. After drug ejections ended, 10-30 s 
elapsed before PFC stimulation (20 Hz, 80 pulses) to measure O2 changes under local iGluR 
antagonism.  
 
Probing Local Glutamatergic Mechanisms with Iontophoresis 
A multimodal sensor was placed in either the cortex or the striatum, with one barrel 
containing glutamate. Each probe was used for multiple locations, if background currents 
remained stable, both to avoid damaging tissue and minimize the number of rats. Recording 
locations were at least 300 µm apart (Belle et al., 2013). 
Glutamate was ejected (2 s) while lowering the sensor. Locations were designated as 
cell locations if they produced reproducible single-unit firing that was time-locked to the 
glutamate ejection. We optimized the depth of cell recording locations to maximize single-unit 
activity in response to glutamate. Data sets were also taken at locations that were insensitive to 
glutamate. Each recording location data set consisted of 3-6 replicates each of baseline O2 
activity (nothing ejected) and 2 s glutamate ejections. Time between subsequent glutamate 
ejections was 120 s. 
 
Histology 
Following data collection, the probe location was lesioned by cyclically applying a ramp 
of 0 – 10 V DC potential manually three times over 20 s. Animals were sacrificed with urethane 
cardiac puncture. Brains were removed and fixed in 10% formalin for >7 days. Brains were then 
cryoprotected in 30% sucrose for >48 hrs, before coronal sections (50 µm) were taken with a 
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freezing microtome (Leica, Germany).  Slices were mounted on microscope slides and viewed 
under a light microscope to confirm electrode placements. 
 
Statistical Analyses 
Statistical analysis was performed using GraphPad Prism 6 (GraphPad Software, San 
Diego, CA, USA). Repeated measures one-way analysis of variance (ANOVA) with post-hoc 
Bonferroni’s test was used to evaluate significance. A Student’s t-test was used to determine 
significance between pre- and post-drug O2 events elicited by electrical stimulation. Differences 
were significant when *P<0.05 and **P<0.01. 
 
Results 
Electrical Stimulations at Glutamate Cell Bodies Evoke O2 Response at Striatal Terminals 
Glutamatergic neurons project from the PFC to medium spiny neurons (MSNs) in the 
striatum (Murase et al., 1993, Parent and Hazrati, 1995). We recorded O2 changes at locations 
where glutamate iontophoresis elicited single-unit activity, that is, at glutamate-sensitive cells. 
Unit activity was evoked during the glutamate ejection and ceased upon stimulation termination. 
These cells were classified as MSNs, the most common neuron type in the striatum (Zhou et al., 
2002), due to their high prevalence within the striatum and based on their waveform shapes. 
Next, we electrically stimulated the PFC to evoke glutamate release in the striatum, and 
recorded subsequent O2 changes. Electrical stimulations interfered with electrophysiology, so 
we were unable to record cellular activity during PFC stimulations. We observed robust, 
reproducible O2 responses that consisted of two distinct phases: the first, Event 1, was a 
decrease in O2, followed by an overcompensating O2 increase to above baseline, termed 
Event 2 (examples in Figure 4.1A-B). These biphasic responses were consistent with 
post-stimulus O2 changes observed locally using amperometry at microelectrodes (Ances et al., 
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Figure 4.1. Electrically-stimulated glutamatergic cell bodies in the PFC elicit biphasic O2 
changes in the striatum. (A) Color plot representation of cyclic voltammetry data recorded 
around a 100 pulse, 20 Hz, 300 µA electrical stimulation as indicated by the grey bar. Abscissa: 
applied voltage; ordinate: acquisition time of the cyclic voltammograms. Background-subtracted 
currents are color coded. (B) Current taken at the reduction potential of O2 (-1.3 V, horizontal 
dotted line) from A was used to determine the time course of [O2] changes. O2 decreases (Event 
1) during the stimulation and subsequently increases above baseline (Event 2) followed 
electrical stimulation. Cyclic voltammograms from each event (insets) confirmed the identity of 
O2, with background subtraction taken at the black dashed line in A. Slight hysteresis was 
attributed to concomitant endogenous ion fluctuations. (C) PFC glutamatergic cell bodies were 
electrically stimulated after a cocktail of AP5 (50 mM) and CNQX (10 mM) was applied at striatal 
terminals for 60 s. Event 1 was significantly attenuated (P=0.001, Student’s t-test) under iGluR 
blockade. (D) Recording locations in the dorsal striatum were verified histologically (n = 6). 
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2001, Offenhauser et al., 2005) and globally with BOLD fMRI (Ances et al., 2001, Offenhauser 
et al., 2005, Hillman, 2014). 
To confirm that glutamate was responsible for the biphasic O2 response, we next 
iontophoresed iGluR antagonists to saturate the recording area prior to electrical stimulations.   
We chose a constant stimulation parameter of 80 pulses delivered at 20 Hz (Figure 4.2). After 
collecting a pre-drug stimulation response, we delivered both the NMDA receptor antagonist 
AP5 (50 mM) and the AMPA receptor antagonist CNQX (10 mM) for 60 s from a single 
iontophoresis barrel attached to the carbon-fiber electrode. After drug delivery, we stimulated 
the PFC again and compared the striatal O2 changes before and after iGluR antagonism. In all 
cases, the post-stimulus O2 decrease (Event 1) significantly diminished under local iGluR 
blockade (t(2,8)=5.0, P=0.001, n=5) to 44.8 ± 11.1% of pre-drug values, while Event 2 was 
unaffected (Figure 4.1C). This confirmed that endogenous glutamate release evoked by PFC 
stimulation in the striatum resulted in post-stimulation O2 decreases that were partially due to 
iGluR activation. 
  
Biphasic O2 Responses Depend on Electrical Stimulation Parameters  
We next investigated the dependence of the observed O2 events on the stimulation 
parameters to explore what stimulus was sufficient to elicit a biphasic response. First, we kept 
stimulation frequencies and amplitudes constant at 20 Hz and 300 µA, respectively, and 
changed the number of stimulation pulses from 10 – 100 pulses (Figure 4.2A). The number of 
locations that responded with biphasic O2 changes increased with the number of stimulus 
pulses (Figure 4.2B). Furthermore, the relationship was linear between both biphasic event 
amplitudes and the corresponding number of stimulation pulses (Event 1: R2=0.990; Event 2: 
R2=0.975, Figure 4.2C). All O2 responses from 10 pulse stimulations were monophasic, so we 
omitted these data from the linear fit. This both confirmed that both mono- and biphasic O2 
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Figure 4.2. PFC electrical stimulations controlled the biphasic O2 response in the striatum 
through the number of applied stimulation pulses. (A) Current traces taken at the O2 reduction 
potential were averaged (n=6). The number of electrical stimulation pulses (p) used are 
indicated to the right of the traces. Stimulation frequency and amplitude were held constant at 
20 Hz, and 300 µA, respectively. Grey bars indicate stimulation durations. Dotted lines indicate 
± SEM. (B) The relative occurrence of biphasic O2 responses to electrical stim increased with 
the number of stimulus pulses. (C) Post-stimulus minima (Event 1) and maxima (Event 2) 
increased linearly (Event 1: R2=0.990; Event 2: R2=0.975) with the number of stimulus pulses. 
Monophasic data (i.e., decreased O2 responses that did not return to baseline within 60 s) were 
excluded from plotted Event 2 points. Error bars indicate ± SEM. 
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Figure 4.3. PFC stimulation frequencies affected the time to reach minimal O2 decreases (i.e., 
Event 1) and subsequent maximal O2 increases (i.e., Event 2) in the dorsal striatum. (A) Current 
traces taken at the O2 reduction potential were averaged (n = 6), with their respective 
stimulation frequencies indicated to the right. The number of biphasic pulses applied and their 
amplitudes were kept constant (80 pulses and 300 µA, respectively). Grey bars indicate 
stimulation durations. Dotted lines indicate ± SEM. (B) Stimulus frequency did not affect whether 
or not the responses were biphasic. (C) The stimulus frequency affected the time to reach 
maximum Event 1 O2 decreases and the subsequent Event 2 O2 increases. Monophasic O2 
responses were excluded from Event 2 statistics. Error bars indicate ± SEM. Significance was 
determined with repeated measures one-way ANOVA and Bonferroni’s post-hoc test. *P<0.05, 
**P<0.01 
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responses can be elicited at the same location, identified that the response type depends on a 
pulse-dependent stimulus threshold, and showed a strong linear relationship between the 
number of stimulation pulses and the resulting O2 event amplitudes. 
To ensure that the pulse-dependent stimulus effects were not caused by an increase in 
total stimulation length, we kept pulse numbers and amplitude constant (120 pulses and 
300 µA, respectively) and tested 5 – 60 Hz frequencies. These frequencies did not affect either 
Event 1 or Event 2 (when applicable) amplitudes (repeated measures one-way ANOVA, 
Bonferroni’s post-hoc, P>0.05), or influence whether responses were mono- or biphasic (Figure 
4.3A-B). However, longer stimulation times significantly increased the time differences between 
stimulation and maximum O2 changes for each event, relative to faster stimulations (one-way 
ANOVA, Event 1: F(6,53)=6.26, P=0.0002; Event 2: F(6,35)=5.47, P=0.003; Figure 4.3C). 
Bonferroni post-hoc analysis revealed significant differences in Event 1 minima times between 
both 5 Hz and 10 Hz stimulations as compared to higher stimulation frequencies (5 Hz: 13.6 ± 
2.5 s; 10 Hz: 13.1 ± 1.0 s; 30 Hz: 6.5 ± 0.5 s; 40 Hz: 6.4 ± 0.8 s; and 60 Hz: 6.2 ± 0.5 s;  5 Hz 
versus 30, 40 and 60 Hz: P<0.01 each, n=6 each; 10 Hz versus 30 and 40 Hz: P<0.05 each; 10 
Hz versus 60 Hz: P<0.01, n=6 each, Figure 4.3C). Time differences between stimulation and 
Event 2 maxima (when present) also increased from 5 Hz and 10 Hz stimulation frequencies to 
60 Hz (5 Hz: 33.1 ± 7.5 s, n=2; 10 Hz: 30.8 ± 2.8 s, n=4; 60 Hz: 18.6 ± 0.5 s; 5 Hz and 10 Hz 
versus 60 Hz:  P<0.05 each, Figure 4.3C). These findings indicated that longer stimulus 
frequencies increased the timespan between electrical stimulus and both Event 1 minima and 
Event 2 maxima, without affecting event magnitudes.  
 
Glutamate Iontophoresis Provokes Local Single-Cell Firing and O2 Consumption 
To exclude the confounding effects of non-specific neurotransmitters released from 
electrical stimulation, we next delivered glutamate directly to the recording locations.  
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Experiments started in the somatosensory cortex as proof of principle, then extended deeper 
within the brain through the striatum. We ejected glutamate from an iontophoresis barrel in 2 s 
pulses as the electrode lowered, until electrophysiology could resolve single-unit firing from 
background noise at the carbon fiber (Figure 4.4A and 4.4C). Cortical cells required >100 nA 
cathodic current to respond, and were most often found at or below 0.9 mm D-V, corresponding 
to the most densely populated layers IV – VIb. These observations were consistent with 
published observations (Krnjević and Phillis, 1963, Dykes and Lamour, 1988, Lamour et al., 
1988), which validated our approach to locally excite cells with iontophoresed glutamate. 
Next, we advanced our experiments into the striatum to investigate differences between 
the role of glutamate between superficial and deep brain environments. Striatal cells were 
denser in the ventral striatum as compared to the dorsal striatum (Meitzen et al., 2011) and 
responded using <80 nA ejection currents, less than the ejection currents required for cortical 
cells (Krnjević and Phillis, 1963) and consistent with previous reports (Kiyatkin and Rebec, 
1996).  Cells required different glutamate ejection currents between and within both brain 
regions, either due to differences in barrel characteristics, distance of the cell to the drug barrel, 
cell sensitivity to glutamate, or the available excitatory receptor populations (Lamour et al., 
1988). However, the consistent difference between the ejection currents required to elicit cell 
firing established that glutamate sensitivities differed between the cortex and striatum. 
We used FSCV to record O2 changes during glutamate iontophoresis and simultaneous 
single-unit activity recording. In contrast to electrical stimulations, we observed one of two 
effects in recorded environments following glutamate iontophoresis: either an exclusive 
monophasic O2 decrease (i.e., Event 1 not followed by Event 2) or negligible O2 changes 
(Figure 4.4). The monophasic O2 decreases returned to baseline within 20 s (Figure 4.4A-B). 
This contradicted a previous study that found a robust O2 increase following local glutamate 
pressure ejection (Lourenço et al., 2014), despite that they delivered 0.5 nmol over 1 s versus
  
 
7
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Figure 4.4. Carbon fiber electrodes detected a variety of microenvironments that respond differently to glutamatergic excitation. (A-
D) Recording locations fell into one of two broad categories: those that responded to glutamate with excitatory single-unit activity (A, 
C) and those that did not (B, D). Within each group, glutamate ejections were either succeeded by an O2 decrease (A, B) or 
experienced no change in O2 relative to baseline (C, D).  Black tics indicate action potentials for each of the four collected trials 
shown. Grey boxes indicate the glutamate ejection duration. O2 traces were taken at the O2 reduction potential. B, C, and D share the 
same scale bar. (E) Differences existed between overlapping spontaneous O2 events, neuronal sensitivity to glutamate, and 
provoked O2 changes in the cortex, striatum (excluding interneurons), and interneuron locations.
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an estimated value on the order of picomoles delivered via iontophoresis ejection over 2 s at our 
chosen ejection currents (Kirkpatrick et al., 2014). Overall, our sensor recorded one of four 
responses to glutamate at any given location, either with or without cell firing and succeeded by 
either O2 consumption or no O2 changes (Figure 4.4), depending on natural heterogeneity.  
 
Glutamate Inhibits Interneuron Activity 
While characterizing glutamate responsive neurons in the striatum, we serendipitously 
observed interneurons in ventral locations, offering us the unique opportunity to study them in 
vivo. These cells represent only 1-3% of striatal neurons (Zhou et al., 2002), and were 
confirmed as interneurons by their high spontaneous firing rate and single-unit waveform. Our 
carbon-fiber microelectrodes recorded 1-3 interneurons per recording location (Figure 4.5A-B), 
consistent with clusters observed by others (Alcantara et al., 2003). They spontaneously fired 
between 10-25 Hz in deeply anesthetized subjects, higher than in previously reported studies 
(Zhou et al., 2002, Witten et al., 2010). Locally ejecting glutamate significantly inhibited, rather 
than augmented, single-unit firing rates (35.8 ± 5.5% of baseline single-unit activity, t(2,24)=11.5, 
P<0.0001, Figure 4.5B-C), and fully extinguished firing with extended ejection times 
(Figure 4.5B). Basal firing rates recovered after glutamate ejections ceased (Figure 4.5B). To 
our knowledge, we are the first to show this explicit chemical relationship between interneurons 
and glutamate in vivo. 
 
Transient O2 Events 
Finally, while characterizing glutamate responses in both cortical and striatal 
environments, we also observed spontaneous, discrete O2 changes throughout both regions 
(Figure 4.6). These transient O2 events occurred without concurrent cell activity, presented 
during baseline recordings in absence of glutamate, and persisted throughout data collections  
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Figure 4.5. Interneurons observed in the ventral striatum. (A) A 2D waveform density plot 
distinguished a cluster of three interneurons firing at a single carbon fiber in one location, each 
resolved from the background. Typical interneuron firing rates (>10 Hz) produced large, dense 
clusters. Color-coded average action potential waveforms, with outliers >4 σ removed, are 
shown above their respective cluster. (B) Firing rate histograms for two interneurons (α and β as 
blue and purple, respectively), recorded at a different location than shown in A. The firing rate of 
both cells attenuated during glutamate ejections and recovered after the ejections ended. The 
dashed lines from left to right represent the start of ejection, end of the 2 s ejection, and end of 
the 10 s ejection. (C) A 2 s glutamate ejection, normalized to the spontaneous firing exhibited by 
these cells, had a powerful inhibitory effect on interneurons in the ventral striatum (Student’s t-
test: t(2,12) = 11.51, P < 0.0001). 
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Figure 4.6. Recording locations exhibited spontaneous O2 transients. (A) A layer Vb cortical 
cell. (B) An MSN in the striatum. (C) An interneuron in the ventral striatum. Each black hash 
(top) indicates a single recorded action potential. Discrete O2 events presented alone, devoid of 
other electrochemical signals (color plots, middle). Current traces (bottom) were obtained by 
setting the background current such that all events were O2 consumption / positive current 
deflection events for consistency. Both cortical and striatal recording locations presented with 
either short, punctuated transients (i.e., A), large, extended transients (i.e., C), or a mixture of 
both (i.e., B).  
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unaffected by glutamate ejections. The overlapping relationships between these transients and 
glutamate-stimulated O2 decreases and single-unit activity between cortical and striatal 
environments are summarized in Figure 4.4E. Interestingly, 90.0% of all recorded locations with 
glutamate-sensitive cells presented with spontaneous O2 transients. These transients appeared 
in 93.7% of striatal, glutamate-sensitive recording locations (excluding interneurons) and 88.6% 
of locations insensitive to glutamate (Figure 4.4E). Spontaneous O2 transients presented at 
80.8% of glutamate-sensitive cortical cell locations, but only 54.8% of glutamate-insensitive 
locations (Figure 4.4E). These data revealed a high probability of observing spontaneous O2 
fluctuations in close proximity to glutamate-sensitive neurons, especially in subcortical brain 
matter, but further studies are needed to determine their significance. 
 
Discussion 
In this study, we extended the use of an existing multimodal sensor to investigate the 
relationship between neuronal activity and O2 consumption in highly-localized environments. We 
assessed the differences between stimulated (non-specific) and iontophoresed (specific) 
glutamate responses. Endogenous glutamate release via electrical PFC stimulation elicited a 
biphasic O2 pattern in the striatum, first decreasing and then increasing above baseline levels, 
consistent with the idea that O2 is first locally consumed (Event 1) following neurotransmission 
before being replenished via CBF increases (Event 2) (Ances et al., 2001, Offenhauser et al., 
2005, Hillman, 2014). Interestingly, we did not observe dopamine release at the sensor, though 
this has been reported in the ventral striatum (Murase et al., 1993). Activation of striatal iGluRs 
was responsible for the magnitude of O2 consumption, but did not affect O2 compensation (i.e., 
CBF). Local O2 responses to glutamate iontophoresis resembled those from weak electrical 
stimulations, monophasic O2 decreases that were insufficient to provoke CBF-driven increases 
in O2. Taken together, it is clear that our improved multimodal sensor provides a chemically and 
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spatially selective method of studying glutamatergic influence on single-unit activity and local O2 
coupling throughout the brain in vivo. 
Here, we stimulated glutamatergic cell bodies in the PFC to measure O2 changes at 
terminals in the dorsal striatum. Typical electrical stimulation paradigms use biphasic pulses and 
optimize stimulation parameters through tuning curves (Mathiesen et al., 1998, Nielsen and 
Lauritzen, 2001, Offenhauser et al., 2005, Hoffmeyer et al., 2007). Studies have reported that 
below a threshold stimulation “strength,” both O2 decreases and cell firing occurred without 
evoking CBF changes (Nielsen and Lauritzen, 2001, Offenhauser et al., 2005). We reproduced 
this phenomenon using glutamatergic PFC projections to the striatum and identified “strength” 
related to the number of stimulating pulses. The event amplitudes grew linearly with the number 
of stimulation pulses, as did the likelihood of the location responding with a biphasic O2 pattern 
(i.e., first consuming O2, then receiving O2 increases above baseline). Together, these results 
support current functional hyperemia dogma that increasing neuronal activity leads to increases 
in energy consumption and subsequent CBF increases to deliver overcompensating amounts of 
O2.Thus, we verified that a stimulation threshold must be exceeded to elicit hyperemic O2 
responses, and identified that the threshold directly depends upon the number of stimulus 
pulses.  
In contrast to previous studies that show both CBF and neuronal activity as dependent 
upon stimulation frequency (Mathiesen et al., 1998, Nielsen and Lauritzen, 2001, Offenhauser 
et al., 2005, Hoffmeyer et al., 2007), we found no relationship between faster stimulation 
frequencies and whether or not the locations expressed biphasic behavior. It is important to note 
that each of these studies kept the stimulation duration constant while modulating the 
frequency, which would confound the effects of frequency with that of the pulse numbers per 
stimulus. Further, we found no relationship between the event amplitudes and frequency, which 
we attribute to using the same number of pulses. Slowing the stimulation frequency only 
lengthened the amount of time between the stimulation and the maximal O2 event responses, 
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which again supported our conclusion that it is the number of pulses that ultimately controls the 
magnitude of O2 responses. Thus, we conclude that frequency has no influence over hyperemia 
as it relates to PFC stimulations recorded in the striatum. 
Event 2 was insensitive to localized iGluR blockade at the cell terminals (Figure 4.1C), 
consistent with studies that related neurovascular coupling to postsynaptic receptor activity 
(Nielsen and Lauritzen, 2001, Iordanova et al., 2015). This suggests that O2 overcompensation 
(i.e., CBF) at striatal terminals stems from activity-dependent, PFC neurotransmission. As a 
sufficient quantity of stimulation pulses was necessary to provoke Event 2, the species 
responsible either required robust, accumulative stimulations to activate or recruited a larger 
population of excited cells. However, the lack of specificity offered by electrical stimulation 
precluded any conclusions about whether this hyperemic relationship depended more on 
neuronal consumption of energy or the release of specific neurotransmitters. 
It is well known that electrical stimulations excite spatially-extensive cell populations, so 
we adapted an existing multimodal sensor to excite local neuronal populations, record action 
potentials, and observe subsequent O2 changes. Delivering glutamate through iontophoresis at 
a carbon-fiber microelectrode evoked single-unit activity in highly-localized cell populations, in 
agreement with previous studies (Krnjević and Phillis, 1963, Lamour et al., 1988). Nearly all 
recorded locations (100+) showed either no O2 changes following a brief (2 s) glutamate 
ejection or a monophasic O2 decrease that returned to baseline (Figure 4.4). The exclusive 
presence of Event 1 following local excitation mirrored a “weak” electrical stimulus, but could not 
elicit biphasic responses even with ejection currents >500 nA (data not shown). Previous work 
in our lab established how to both quantify the amount of ejected drug and track its spatial 
diffusion (Kirkpatrick et al., 2014, Kirkpatrick and Wightman, 2016), which we used to confirm 
that a 2 s ejection released glutamate on the order of pmol despite the 200 mM barrel 
concentration. This quantity is unlikely to be excitotoxic (Choi, 1988), which establishes 
glutamate iontophoresis as a safe method of investigating local stimulation dynamics. However, 
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this concentration is likely too low to diffuse to a sufficient number of neurons to match the 
stimulation strength necessary to elicit a biphasic response, especially with the efficiency of 
glutamate uptake through neuronal and astrocytic transporters (Rothstein et al., 1996). 
Cell firing is normally inhibited in deeply anaesthetized animals; however, we observed 
highly-active interneurons in the ventral striatum. We could not characterize whether these 
interneurons were cholinergic or GABAergic based on electrophysiological recordings alone 
(Kawaguchi, 1993). Through iontophoresis, we discovered that glutamate significantly and 
reversibly inhibited, rather than excited, interneuron firing rates. Other studies have shown 
contrary relationships between MSN and cholinergic interneuron activity in vivo (Zhou et al., 
2002, Witten et al., 2010). The specific glutamatergic inhibition of these interneurons adds to the 
growing body of literature investigating the complex interactivity between glutamate, dopamine, 
and acetylcholine through striatal MSNs and interneurons (Gras et al., 2002, Alcantara et al., 
2003, Surmeier et al., 2007).  
Spontaneous O2 events, found here in both the cortex and striatum, were observed in 
vivo as early as 1957 (Davies and Bronk, 1957). One study reported that adenosine, a 
vasoactive neurotransmitter, synchronized with a percentage of O2 transients in the dorsal 
striatum (Wang and Venton, 2016). Studies attributed these spontaneous events to factors 
ranging from the type of anesthetic used (Hudetz et al., 1998) to spontaneous astrocytic 
excitation (Volterra and Meldolesi, 2005, Khakh and Sofroniew, 2015), among other 
possibilities. Studies detecting O2 using amperometry showed baseline current fluctuations, 
(Lowry et al., 2010) and other works by Lowry et al., but the unique cyclic voltammogram shape 
allowed us to confirm what may be mistaken for noise as O2 (examples shown in Figure 4.1B). 
Though some transients were large (>20 µM), the short (<60 s) durations, continued sensitivity 
to glutamate excitation, and lack of concomitant ionic signals precluded these from representing 
spreading depolarization events (Ayata and Lauritzen, 2015). The larger percentage of 
transients observed in deeper brain regions indicated an environmental factor to their presence, 
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though we did not investigate any underlying chemical or physical source(s). When glutamate 
was ejected during a transient event, we observed augmented O2 decreases that relaxed on the 
same time scale as those not confounded by transients, indicating that the spontaneous events 
throughout the brain are unlikely to be competing with glutamate-receptor-dependent O2 
consumption. Our measurements indicated that spontaneous O2 events did not correspond with 
single-unit firing, but the large overlap between the presence of transients and glutamate 
sensitive neurons could make multi-unit cellular recording a future topic of exploration. 
 
Conclusions 
As technology progresses to stimulate the brain more selectively and specifically, 
increasing evidence suggests that disconnects between cerebrovascular coupling relationships 
exist in healthy subjects. Here, we elicited a hyperemic response from electrically stimulated 
glutamate release in the striatum, but targeted exogenous glutamate excitation produced only 
decreases in recorded O2. Modifying an existing multimodal sensor that pairs iontophoresis with 
electrophysiology and FSCV permitted the simultaneous detection of highly localized O2 and cell 
firing responses to selective glutamatergic stimuli in an intact animal. This technique serves as a 
starting point for investigating spatially-targeted cerebrovascular coupling as it relates to 
glutamate-elicited neuronal spiking and O2 consumption.  
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CHAPTER 5: GLUTAMATE RECEPTOR ROLES IN LOCALIZED COUPLED AND 
DECOUPLED SINGLE-UNIT FIRING AND O2 RELATIONSHIPS BETWEEN THE CORTEX 
AND NUCLEUS ACCUMBENS 
 
Introduction 
Regional increases in cerebral blood flow (CBF) maintain energetic homeostasis during 
neuronal activity in a process known as neurovascular coupling (Attwell et al., 2010). Glutamate 
is ubiquitous throughout the brain and is the primary excitatory neurotransmitter responsible for 
synaptic neurotransmission. Glutamate receptors are present on glial cells and both pre- and 
post-synaptic neurons, providing multiple pathways through which glutamate can influence 
neurovascular coupling. Dysregulated glutamatergic receptor function has been implicated in 
numerous pathologies including Huntington’s (Cowan and Raymond, 2006), schizophrenia 
(Olney and Farber, 1995), and many others (Meldrum, 2000, Niswender and Conn, 2010, 
Paoletti et al., 2013). Interestingly, these same disease states are associated with dysregulated 
CBF (Zlokovic, 2011). Although glutamate is known to contribute to neurovascular coupling 
through its different receptors (Attwell et al., 2010), the precise mechanisms of this influence are 
poorly understood. 
A growing number of brain functionality studies use blood oxygen level dependent 
(BOLD) functional magnetic resonance imaging (fMRI), which measures shifts in oxygenated 
and deoxygenated blood that depend on CBF changes (Ogawa et al., 1990). However, data 
interpretation is the subject of much debate since fMRI infers neuronal activity based on 
hemodynamic signals. Although this is valid when neurovascular coupling is conserved, it may 
not apply to comparisons between brain regions where coupling is modulated differently (Ances 
et al., 2008, Sloan et al., 2010). Additionally, the poor spatial resolution (~1-2 mm) homogenizes 
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signals within brain regions that differ locally. Glutamate receptors express differentially 
throughout the brain at a local level (Petralia et al., 1996), and signal averaging at this scale 
may not be appropriate for studying the influence of these receptors in neurovascular coupling. 
Finally, these studies are “functional” studies by definition, meaning that they differentiate brain 
activity during task performance, or following peripheral or electrical stimulations. These stimuli 
are not selective, and off-target effects may confound data interpretation. Therefore, to study 
glutamatergic influence on neurovascular coupling requires a technique that can eliminate the 
off-target effects of nonselective stimuli as well as address the differential distribution of receptor 
types within and between brain regions. 
Herein we expound upon previous work using a multimodal sensor to reveal definitively 
that glutamate, acting through specific receptors, affects coupling between single-unit activity 
and O2 consumption in the somatosensory cortex and the nucleus accumbens (NAc). First, we 
antagonized ionotropic glutamate receptors (iGluRs) and found that in both regions, α-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid and kainate receptor (AMPARs collectively) 
antagonism decoupled neuronal activity and O2, whereas N-methyl-D-aspartic acid receptor 
(NMDAR) antagonism maintained this relationship. Next, we assessed the impact of 
metabotropic glutamate receptors (mGluRs), comparing the use of iGluR antagonists and an 
mGluR agonist. Both the cortex and NAc had coupled and decoupled responses between these 
two treatments. Furthermore, we inhibited nitric oxide synthase (NOS), which diminished 
responses and maintained coupling in the cortex but showed nNOS-specific decoupled 
responses in the NAc. Taken together, our data show that activated glutamate receptors exert 
differential effects on single-unit activity and O2 changes between and within different brain 
regions at high spatial resolutions, which is an important consideration in the interpretation of 
fMRI data.  
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Experimental 
Animal Care 
All animal protocols were approved by the Institutional Animal Care and Use Committee 
of the University of North Carolina at Chapel Hill (UNC). Sprague-Dawley rats (adult males, 300 
– 450 g, Charles River, Wilmington, MA, USA) were pair-housed in UNC animal facilities on a 
12 hour light/dark cycle and given food and water ad libitum. Care was taken to reduce the 
number of animals used and minimize their suffering. A total of 50 animals were used (35 for 
cortical measurements overlapping with 28 for NAc), with each animal providing 1-6 location 
data sets. 
 
Surgery 
Animals were anesthetized with urethane (1.5 g/kg i.p.) and placed in a stereotaxic 
frame (Kopf, Tujunga, CA, USA). Holes were drilled for recording electrodes in the NAc (+2.2 
mm A-P, +1.7 mm M-L, -6.4 to -7.8 mm D-V) or somatosensory cortex (+0.6 mm A-P, +2.8 mm 
M-L; +2.0 mm A-P, +2.6 mm M-L, -0.9 to -2.0 mm D-V for each) (Hall and Lindholm, 1974, 
Hoffmeyer et al., 2007). Coordinates are referenced from bregma according to the atlas of 
Paxinos and Watson (2007). A Ag/AgCl wire placed in the contralateral hemisphere served as 
an iontophoresis ground and reference electrode.  
 
Drugs and Solutions 
NMDA, AMPA, 1,2,3,4-tetrahydro-7-nitro-2,3-dioxoquinoxaline-6-carbonitrile disodium 
salt (CNQX, AMPAR antagonist), DL-2-amino-5-phosphonopentanoic acid sodium salt (AP5, 
NMDAR antagonist), Nω-propyl-L-arginine hydrochloride (L-ARG, neuronal nitric oxide synthase 
[nNOS] inhibitor), 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine hydrochloride (MTEP, mGluR5 
antagonist), and dihydrokainic acid (DHK, GLT-1 glutamate transporter blocker) were purchased 
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from Abcam (Cambridge, MA, USA). NG-Nitro-L-arginine methyl ester hydrochloride (L-NAME, 
nitric oxide synthase [NOS] inhibitor) and (±)-1-aminocyclopenate-trans-1,3-dicarboxylic acid 
(ACPD, group I/II mGluR agonist) were acquired from Tocris Bioscience (Ellisville, MO, USA). 
All other chemicals were purchased from Sigma Aldrich (St. Louis, MO, USA).  
All drugs were dissolved in 5 mM NaCl. All solutions except L-NAME, L-ARG, and MTEP 
incorporated 0.5 mM uric acid as an inert, electroactive tracer and were ejected with cathodic 
currents (-25 to -400 nA). Drugs ejected with anodic current (+30 to +150 nA; L-NAME, L-ARG, 
and MTEP) were adjusted to pH 6-7 using 0.1 M NaOH and used 4-methylcatechol as an inert 
tracer with concentrations matching that of the drug (Bucher et al., 2014). 
 
Voltammetric O2 Measurements and Iontophoresis 
Mutimodal sensors were fabricated as described previously (Belle et al., 2013). A 5 µm 
diameter carbon fiber, pulled into a glass capillary, was inserted into a 4-barrel capillary and cut 
under a light microscope to an exposed length between 80 - 120 µm. The three remaining 
barrels were filled with drug solutions. 
Fast-scan cyclic voltammetry (FSCV) measurements were controlled using High-
Definition Cyclic Voltammetry (HDCV) software (Bucher et al., 2013). The cyclic voltammetry 
waveform scanned from a holding potential of 0.0 V to +0.8 V, then to -1.4 V, and finally back to 
the holding potential (all vs. Ag/AgCl reference electrode) over an 11 ms time span. The 
voltammetric scan rate was 400 V s-1.  Carbon-fiber surfaces were conditioned in the brain by 
cycling the waveform at 60 Hz, then 10 Hz, for 15 minutes each. Data were collected at 5 Hz 
during simultaneous electrochemical and electrophysiological measurements as described 
previously (Takmakov et al., 2011). Custom instrumentation controlled the connection of the 
carbon fiber alternately between a current transducer (for cyclic voltammetry) and a voltage 
follower (single-unit activity measurements) (Takmakov et al., 2011). 
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Iontophoretic ejections were performed by applying constant current (NeuroPhore BH-2 
System, Harvard Apparatus, Holliston, MA, USA). A data acquisition program controlled ejection 
timing (HDCV, UNC Chapel Hill, Chapel Hill, NC). Iontophoresis barrels were primed at least 
400 µm dorsal to the measurement region (-0.5 mm D-V cortex, -5 to -6 mm D-V NAc) to ensure 
reproducible ejections. Baseline experiments collected voltammetry data in absence of chemical 
or electrical stimulation. 
 
Single-Unit Activity Electrophysiology 
Single-unit activity was measured for 179 ms between each cyclic voltammetric scan.  
The data were amplified (x5,000), fed through a bandpass filter (300 – 3,000 Hz, Krohn-Hite 
Corp., Brockton, MA), and digitized using commercially available software (Digitizer, Plexon, 
Dallas, TX, USA). 
 
Data Analysis 
Cyclic voltammetry data were background subtracted and filtered using a 4th order low 
pass Bessel filter with a 2 kHz cutoff frequency. Data are summarized in color plots that show 
current magnitude in false color, voltages from the waveform along the ordinate, and time along 
the abscissa. A calibration factor of -0.35 nA µM-1 for O2 was obtained from a calibration curve 
as shown previously (Bucher et al., 2014). Concentration data were normalized to the glutamate 
response in absence of drug (“control”) prior to statistical analysis. Principal component 
regression (PCR) was utilized to confirm that faradaic currents resulted only from O2 or drug 
(Rodeberg et al., 2015). O2 PCR training sets for every electrode were built from naturally 
occurring transients (Walton et al., 2016). Glutamate PCR training sets were built from 
ejections, and drug PCR training sets were built from drug only ejections during times when O2 
transients were not present as determined by background subtraction.  
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Single units were analyzed using Offline Sorter, which uses principle component 
analysis to sort different events (Plexon, Dallas, TX, USA). Firing rate statistics from perievent 
event histograms were exported from NeuroExplorer (NexTechologies, Madison, AL).  
 
Probing Local Glutamatergic Mechanisms with a Multimodal Sensor 
A multimodal sensor, described in previous work (Walton et al., 2016), was placed in 
either the cortex or the NAc. One barrel contained glutamate (200 mM) and one or both of the 
remaining two barrels contained drugs of interest. Each electrode was used for 1-6 locations if 
background currents remained stable, both to avoid damaging tissue and minimize the number 
of rats. Recording locations were acquired at least 300 µm apart (Belle et al., 2013). 
We ejected glutamate (2 s) while lowering the multimodal sensor to locate cells. Only 
locations exhibiting reproducible single-unit activity time-locked to glutamate ejections were 
defined as cells. A full data set included 3-6 replicates each of the following: 1.) A 2 s glutamate 
ejection (control); 2.) A 120 s drug ejection; 3.) A 120 s drug ejection with co-ejection of 
glutamate from 60-62 s; and 4.) A recovery set of 2 s glutamate ejections taken 10 minutes after 
the last drug ejection file (Figure 5.1A). The order of 2 and 3 was randomized. Time between 
glutamate ejections was 120 s in control and recovery files. Time between drug files was 200-
300 s to allow for drug clearance.  
 
Glutamate Receptor Pharmacology in the Somatosensory Cortex 
NMDARs were antagonized using AP5 (50 mM). AMPARs were antagonized with CNQX 
(10 mM). Whenever the third iontophoresis barrel was available, either agonist NMDA (100 µM) 
or AMPA (200 µM) were used to qualitatively confirm excitatory effects.  
To raise endogenous extracellular glutamate and investigate the effect of tonic mGluR 
activation, we iontophoresed an iGluR antagonist cocktail of AP5 (35 mM) and CNQX (18 mM), 
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with a glutamate transporter GLT-1 blocker (DHK, 10 mM). In a parallel experiment, we 
agonized group I and II mGluRs with ACPD (6 mM). To examine the influence of downstream 
nitric oxide (NO) synthesis on glutamate-induced O2 consumption, we inhibited NOS activity 
with L-NAME (5 mM).   
 
Glutamate Receptor Pharmacology in the Nucleus Accumbens 
We used similar pharmacological manipulations in the NAc as in the cortex. In addition, 
we investigated the neuronal contributions to NO production using L-ARG (5 mM) to inhibit 
nNOS over endothelial and inducible NOS (eNOS and iNOS, respectively). We then used 
MTEP (10 mM) to antagonize mGluR5, as it is most prevalent mGluR in the NAc (D'Ascenzo et 
al., 2007). 
 
Histology 
Following data collection, the last electrode location was marked by cyclically applying a 
ramp of 0 – 10 V DC potential manually three times over 20 s to generate a lesion. Animals 
were sacrificed with urethane cardiac puncture. Brains were removed and fixed in 10% formalin 
for >7 days. Brains were then cryoprotected in 30% sucrose for >48 hr, before coronal sections 
(50 µm) were taken with a freezing microtome (Leica, Germany). Slices were mounted on 
microscope slides and viewed under a light microscope to confirm lesion locations. 
 
Statistical Analyses 
Statistical analysis was performed using GraphPad Prism 6 (GraphPad Software, San 
Diego, CA, USA). The average single-unit activity during 2 s glutamate ejections served as the 
100% cell firing control. The apex of O2 consumption within 15 s of the glutamate ejection 
served as the 100% O2 control. Significance between glutamate excitation before, during, and 
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after drug application was evaluated using a repeated measures one-way analysis of variance 
(ANOVA) with a Geisser-Greenhouse (G-G) correction and a post-hoc Dunnett’s multiple 
comparisons test versus control (100%). Data are presented as the mean ± SEM and n values 
representing the number of unique recording locations.  Any locations that lacked O2 responses 
were excluded from O2 analysis, though the single-unit activity data was included if present. A 
Student’s t-test was used to evaluate significance between split cell populations. P values <0.05 
were considered significant. 
 
Results 
Glutamate Iontophoresis Evokes Changes in Single-Unit Activity and O2 Consumption 
First, we chose to validate our previous approach for assessing concomitant single-unit 
activity and O2 concentration changes using a multimodal sensor (Walton et al., 2016). We 
measured single-unit activity and O2 concentration changes evoked by local glutamate ejection 
(example in Figure 5.1B-C). As before, we confirmed that glutamate ejections were not 
excitotoxic (Figure 5.2). Using the same ejection current, we recorded three sequential trials 
each of 5, 10, and 20 s glutamate ejections (200 mM) and spaced the ejections 120 s apart 
(Figure 5.2). These stimuli elicited single-unit firing, but did not injure or desensitize cells, even 
during the longest (20 s) ejection time (Figure 5.2C), consistent with previous studies that used 
near-saturated glutamate concentrations (Krnjević and Phillis, 1963). We used PCR training 
sets to separate O2 currents from glutamate ejection currents (Figure 5.2, top). Though these 
traces appeared noisy due to natural, spontaneous O2 transients (Walton et al., 2016), residual 
plots (Figure 5.2, bottom) confirmed that the current due to noise was below a training set 
specific predicted threshold value (Qα) and thus validated the PCR analysis (Rodeberg et al., 
2015). We found that, regardless of ejection duration, locations continued to respond with O2 
decreases (Figure 5.2). These observations were consistent with our previous report, and 
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Figure 5.1. Experimental paradigm to assess the differences between single-unit activity and O2 
responses to glutamate excitation with and without pharmacological manipulation. (A) Protocol 
schematic. (B) (i) A single-unit waveform recorded in the NAc. (ii). PCR extracted neuronal 
activity from background noise, visualized in 2-D waveform density plots. The central black 
cluster represents noise waveforms, while the cluster outlined in red represents the single unit 
from (i) resolved from background. (C) Glutamate ejections evoked single-unit firing and O2 
decreases. (Top) The cell in A, exposed to a 2 s glutamate ejection. (Bottom) The same cell as 
above exposed to the drug and glutamate paradigm. The drug example shown is ACPD (mGluR 
agonist). Black tics indicate single-unit action potentials. Below them are PCR extracted O2 
traces from cyclic voltammetry currents. Dashed lines indicate baseline current. The grey box 
indicates glutamate ejection time, and the red box indicates drug ejection time. 
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confirmed that glutamate iontophoresis at our chosen barrel concentration would evoke reliable 
single-unit activity and O2 changes without excitotoxic effects. 
 
Single-Unit Activity and O2 Consumption Couple and Scale with Glutamate Ejection Currents 
across Sensors 
 
Previous work established that drug quantities ejected using the same ejection currents 
are inconsistent between iontophoresis barrels (Herr et al., 2008). To ensure that we could 
average data collected across many of our multimodal sensors, we next ejected glutamate 
using 5-300 nA currents at multiple (n=6) electrodes in both cortex and NAc locations. When we 
normalized single-unit activity and O2 concentrations to the maximum ejection current, we found 
a linear relationship between ejection current and single-unit activity (R2=0.71, Figure 5.3), and 
between ejection current and O2 consumption (R2=0.75, Figure 5.3) across multiple electrodes. 
Additionally, the O2 consumed and single-unit responses correlated (Pearson’s correlation, 
P<0.0001). Therefore, normalizing cell firing and O2 data provided a meaningful way to compare 
data between these multimodal sensors.  
 
Neuronal Activity and O2 Remain Coupled in the Somatosensory Cortex During NMDAR, but 
Not AMPAR, Antagonism 
 
We determined in a previous study that iGluRs influenced glutamate-induced O2 
consumption, which couples to single-unit activity (Walton et al., 2016). To investigate the 
individual contributions of iGluRs to coupled single-unit activity and O2 concentration changes, 
we used our multimodal sensor to eject antagonists and compare pre-drug responses to 
glutamate excitation against responses during drug delivery (example in Figure 5.1C). We used 
AP5 to antagonize NMDARs and CNQX to antagonize AMPARs. Both AP5 and CNQX 
significantly reduced glutamate-elicited cell firing in the cortex, (AP5: F=4.4, P=0.053; 45.0 ±  
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 Figure 5.2. Extended glutamate iontophoresis (200 mM) was not excitotoxic. (Top) PCR 
extracted O2 current traces for 5 s (A), 10 s (B), and 20 s (C) glutamate ejection times, each 
represented by grey boxes. Black tics represent single-unit action potentials. Dashed lines 
indicate baseline current. (Bottom) Corresponding PCR residual currents are below the 
anticipated noise threshold, and do not contain signals that indicate the presence of other 
analytes. The data shown are from a NAc location. 
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Figure 5.3. Single-unit activity and local O2 consumption responded linearly with increasing 
ejection currents. All data are normalized to the values obtained at the highest ejection current 
used with each sensor. Each point represents an average of three repeated trials using the 
same current (n=6 locations). Error bars are omitted for clarity. 
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9.6%, n=10, Dunnett’s post-hoc P<0.001; CNQX: F=20.1, P<0.0001; 53.0 ± 6.7%, n=9, 
Dunnett’s post-hoc P<0.001; Figure 5.4A); however, cells exposed to CNQX did not recover to 
pre-drug firing rates (69.7 ± 7.4% of control, n=9, Dunnett’s post-hoc P<0.01; Figure 5.5A).  
Surprisingly, NMDAR and AMPAR antagonism exerted differential effects on glutamate-
elicited O2 consumption. NMDAR antagonism with AP5 significantly reduced both the magnitude 
of O2 consumption in the cortex (F=14.6, P=0.0007; 48.5 ± 6.6%, n=10, Dunnett’s post-hoc 
P<0.0001; Figure 5.4A), and the time to reach maximum O2 consumption (9.8 ± 0.96 s before 
drug vs. 6.7 ± 0.77 s during drug; t(2,20)=2.5, P=0.022; Figure 5.6). In contrast, O2 consumption 
during AMPAR antagonism with CNQX did not decrease (Dunnett’s post-hoc P>0.05, Figure 
5.4A), despite reduced single-unit activity. These data indicated that glutamatergic excitation 
conserved neuronal activity and O2 consumption coupling in the cortex and NAc with 
antagonized NMDARs, whereas glutamate unilaterally diminished neuronal firing without 
altering O2 responses in the case of AMPAR antagonism. 
 
Single-Unit Activity and O2 Consumption in the Somatosensory Cortex Decrease During iGluR 
and GLT-1 Blockade, but Decouple with Exclusive mGluR Agonism 
 
Because mGluRs are known to exert influence over vasculature through astrocytes 
(Zonta et al., 2003, Petzold et al., 2008, Carmignoto and Gómez-Gonzalo, 2010), we 
investigated whether agonizing these receptors would affect O2 responses. First, we ejected a 
cocktail consisting of AP5, CNQX, and the glutamate transporter inhibitor DHK to raise 
endogenous glutamate concentrations while blocking iGluR activation. During ejection of this 
cocktail, glutamate-induced firing significantly decreased (F=20.9, P=0.002; 7.3 ± 4.0%, n=7, 
Dunnett’s post-hoc P<0.0001; Figure 5.4B), as did O2 consumption (F=17.2, P=0.019; 
41.2 ± 4.3%, n=4, Dunnett’s post-hoc P<0.01; Figure 5.4B). We applied the group I/II mGluR 
agonist, ACPD, to isolate mGluR agonism without the confounding factor of the iGluR blockade. 
The result was a significant decrease in firing (F=3.1, P=0.12; 43.7 ± 10.0% of control, n=8,   
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Figure 5.4. Single-unit activity and O2 coupling in the cortex was conserved through 
pharmacological manipulations. (A) iGluR antagonism. (B) Direct and indirect mGluR agonism. 
(C) NOS inhibition. Values are percentages of the corresponding control values, defined as the 
single-unit activity firing and O2 consumption following a 2 s ejection of glutamate (200 mM). 
Values in each bar indicate the number of locations. Error bars indicate SEM. Dotted line 
represents 100% control values. Drug targets are as follows: AP5, NMDAR antagonist; CNQX, 
AMPAR antagonist; DHK, GLT-1 transporter blocker; ACPD, group I/II mGluR agonist; L-NAME, 
NOS inhibitor. Significance was established using a one-way, repeated measures ANOVA. 
Dunnett’s post-hoc significance versus control: *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 
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Figure 5.5. With the single exception of single-unit activity under AMPAR antagonism, all 
cortical cells recovered to control (i.e., pre-drug glutamate) levels following a drug washout 
period. (A) iGluR antagonism. (B) Direct and indirect mGluR agonism. (C) NOS inhibition. 
Values are percentages of the corresponding control values, defined as the single-unit activity 
firing and O2 consumption following a 2 s ejection of glutamate (200 mM). Error bars indicate ± 
SEM. Dotted line represents 100% control values. Drug targets are as follows: AP5, NMDAR 
antagonist; CNQX, AMPAR antagonist; DHK, GLT-1 transporter blocker; ACPD, group I/II 
mGluR agonist; L-NAME, NOS inhibitor. Significance was established using a one-way, 
repeated measures ANOVA. Dunnett’s post-hoc significance versus control: **P<0.01 
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Figure 5.6. NMDAR antagonism using AP5 significantly reduced the amplitude of O2 
consumption and the time to maximum O2 consumption via glutamate stimulation (t(2,20)=2.5, 
P=0.022). Solid lines indicate current traces from cyclic voltammetry data taken from the O2 
reduction potential. Dotted lines represent SEM. Grey box indicates time of glutamate 
iontophoresis. 
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Dunnett’s post-hoc P<0.01; Figure 5.4B) without significant changes to O2 consumption 
(Dunnett’s post-hoc P>0.05, Figure 5.4B). Together, these data indicated that blocking 
glutamatergic influence through iGluRs produced coupled decreases in evoked single-unit firing 
and O2 consumption, but that extended periods of mGluR activation attenuated cell firing without 
affecting O2 changes. 
 
NOS Inhibition in the Somatosensory Cortex Diminishes Single-Unit Activity and O2 Responses 
Activation of NMDARs results in the downstream synthesis of the vasodilative 
neurotransmitter NO (Faraci and Brian, 1994). To test if the synthesis of this vasoactive 
molecule affected O2 consumption, we locally inhibited nitric oxide synthase (NOS) using L-
NAME. Surprisingly, NOS inhibition significantly attenuated cell firing (F=4.7, P=0.063; 
35 ± 7.7%, n=8, Dunnett’s post-hoc P<0.001; Figure 5.4C) and decreased the magnitude of O2 
consumption (F=3.8, P=0.065; 73.1 ± 8.8%, n=7, Dunnett’s post-hoc P<0.05; Figure 5.4C). This 
indicated that NOS inhibition reduces the amount of O2 consumed following glutamatergic 
excitation, however this effect might be attributed to NOS suppression of local single-unit firing. 
  
iGluR Antagonism Exerts Similar Control over Single-Unit Activity in Both the Cortex and NAc 
The NAc is a subcortical region with basal glutamate concentrations similar to the 
somatosensory cortex (Baker et al., 2003, Homola et al., 2006), although it differs in its neuronal 
architecture. This similarity prompted us to study whether glutamate exerted the same 
neurovascular influence in the NAc as compared to the cortex. First, we antagonized iGluRs to 
see whether local NAc environments would respond the same way as in the cortex. Both 
antagonizing NMDARs with AP5 and AMPARs with CNQX significantly attenuated single-unit 
firing (AP5: F=9.7, P=0.006; 38.7 ± 9.5%, n=8, Dunnett’s post-hoc P<0.001; CNQX: F=5.9, 
P=0.019; 56.2 ± 11.4%, n=9, Dunnett’s post-hoc P<0.01; Figure 5.7A). Glutamate stimulations  
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Figure 5.7. Single-unit activity and O2 coupling in the NAc was not always conserved during 
pharmacological manipulations of iGluRs, mGluRs, and NOS. (A) Overall results of iGluR 
antagonism. (B) Correlation plot relating single-unit activity and O2 consumption for AP5 results. 
(C) Overall direct and indirect mGluR agonism responses. (D) Correlation plot relating single-
unit activity and O2 consumption for ACPD results. (E) Overall NOS inhibition responses. (F) 
Correlation plot relating single-unit activity and O2 consumption responses to specific nNOS 
inhibition (L-ARG) and non-specific NOS inhibition (L-NAME). Values are percentages of the 
corresponding control values, defined as the single-unit activity firing and O2 consumption 
following a 2 s ejection of glutamate (200 mM). Error bars indicate SEM. Dotted lines represent 
100% control values. Drug targets are as follows: AP5, NMDAR antagonist; CNQX, AMPAR 
antagonist; DHK, GLT-1 transporter blocker; ACPD, group I/II mGluR agonist; MTEP, mGluR5 
antagonist; L-NAME, NOS inhibitor, L-ARG, nNOS inhibitor. Significance between control and 
drug effects was established using a one-way, repeated measures ANOVA and Dunnett’s post-
hoc versus control: *P <0.05, **P < 0.01, and ***P < 0.001. Significant differences between 
multiple responses to a drug were established using an unpaired, 2-tailed t-test: †P <0.05. 
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Figure 5.8. Cells in the NAc recovered from iGluR antagonists and nNOS inhibition, but other 
drugs continued to diminish single-unit activity after a drug washout period. (A) Overall results of 
iGluR antagonism recovery. (B) Overall direct and indirect mGluR agonism recovery responses. 
(C) Correlation plot relating single-unit activity and O2 consumption for partial ACPD recovery. 
(D) Overall NOS inhibition responses. (E) Correlation plot relating single-unit activity and O2 
consumption recovery responses from specific nNOS inhibition (L-ARG) and non-specific NOS 
inhibition (L-NAME). Values are percentages of the corresponding control values, defined as the 
single-unit activity firing and O2 consumption following a 2 s ejection of glutamate (200 mM). 
Error bars indicate SEM. Dotted line represents 100% control values. Drug targets are as 
follows: AP5, NMDAR antagonist; CNQX, AMPAR antagonist; DHK, GLT-1 transporter blocker; 
ACPD, group I/II mGluR agonist; MTEP, mGluR5 antagonist; L-NAME, NOS inhibitor, L-ARG, 
nNOS inhibitor. Significance was established using a one-way, repeated measures ANOVA. 
Dunnett’s post-hoc significance versus control: *P<0.05. Significant differences between 
multiple responses to a drug were established using an unpaired, 2-tailed t-test: †P <0.05. 
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under both NMDAR and AMPAR antagonism showed no O2 changes relative to control 
(Dunnett’s post-hoc P>0.05, Figure 5.7A). However, NMDAR antagonism with AP5 reduced 
both cell firing and O2 consumption in the majority of locations with two distinct O2 consumption 
outliers, which may indicate either partial decoupling as a result of this drug, or two discrete 
neuron populations that respond differently (Figure 5.7B). There was no significant correlation 
between single-unit activity and O2 consumption (Pearson’s P>0.05, Figure 5.7B). Each location 
fully recovered from both drugs (Figure 5.8A). With few exceptions, glutamate acting through 
iGluRs exhibited similar control over single-unit firing and O2 consumption changes in the NAc 
as in the somatosensory cortex. 
 
Neuronal Activity and O2 Consumption in the NAc Decouple During iGluR and GLT-1 Blockade, 
but Partially Decouple During mGluR Agonism 
 
Due to the similarities in iGluR regulation of single-unit firing and O2 consumption 
between the cortex and NAc, we next asked if mGluR agonism was similar between the two 
brain regions. First, a cocktail of AP5, CNQX, and DHK blocked extracellular glutamate uptake 
and antagonized iGluRs, resulting in significant attenuation of single-unit activity (F=23.1, 
P=0.0014; 21.3 ± 7.3%, n=6, Dunnett’s post-hoc P<0.001; Figure 5.7C). Surprisingly, this did 
not affect O2 consumption (Dunnett’s post-hoc P>0.05, Figure 5.7C). We then ejected ACPD to 
agonize mGluR groups I/II without the iGluR blockade. The results differed from both the 
cocktail in the NAc and the effects of ACPD in the cortex, with a slight decrease in cell firing 
(F=5.7, P=0.03; 60.2 ± 16.6%, n=8, Dunnett’s post-hoc P=0.08; Figure 5.7C) and no decrease 
in O2 consumption (F=1.8, P=2.1; 66.9 ± 12.6%, n=8, Dunnett’s post-hoc P>0.05; Figure 5.7C). 
Interestingly, mGluR group I/II agonism with ACPD also produced disparate responses in NAc 
locations: five locations showed decreased cell firing and three locations remained unaffected in 
terms of cell firing, with a difference in variance between subjects in addition to drug treatment 
(F=3.2, P=0.03; Figure 5.7D). It is worth noting that both responses were found in the same 
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subject with the same probe in two different subjects, and thus experimental error is not likely a 
source of these dissimilarities. Further, these data showed a significant correlation (Pearson’s 
R2 = 0.64, P=0.02; Figure 5.7D), indicating that ACPD either partially decouples single-unit firing 
and O2, or that the drug effects differed depending on the location within the NAc. Finally, the 
locations treated with ACPD that did show slight decreases in cell firing and O2 consumption did 
not recover to pre-drug metrics and no longer correlated after the recovery epoch (Pearson’s 
P>0.05; Figure 5.8C). These responses indicated that mGluR agonism affected O2 consumption 
differently between the NAc and the cortex in the presence of an iGluR blockade. Additionally, 
the responses in the NAc showed partial decoupling of cell firing and O2 consumption in 
response to mGluR agonism that corresponded with whether or not these metrics recovered 
after drug washout. 
 
mGluR5 Antagonism Affects Neuronal Firing in the NAc in Two Different Ways 
The majority of NAc mGluRs are located pre-synaptically (mGluR3), post-synaptically 
(mGluR1), or both perisynaptically and on astrocytes (mGluR5) (D'Ascenzo et al., 2007, Mitrano 
et al., 2010). To investigate the split results of extended mGluR activation with ACPD, we used 
an mGluR5-specific antagonist, MTEP, to see whether modulating the activities of this specific 
mGluR also produced a split population of cell responses. Though all cells collectively 
responded with decreased single-unit activity under mGluR5 antagonism, we made the 
interesting observation that MTEP increased basal firing rates at some locations (Figure 5.9). 
We separated locations where cells responded to the drug itself from those that did not change 
baseline firing, and found a significant split between the cell firing values (t(2,8)=2.6,P=0.029; 
Figure 5.7C). These populations further differed in their ability to recover sensitivity to glutamate 
after drug washout. Cells excited by MTEP showed significantly diminished single-unit activity 
responses to glutamate ejections during MTEP (F=16.8, P=0.0051; 42.0 ± 7.6% n=5, Dunnett’s  
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Figure 5.9. MTEP (mGluR5 antagonist) ejections in the NAc affected single-unit activity in one 
of two ways. Shown is a raster plot where tic marks indicate action potentials. (Left) Baseline 
firing activity in absence of drug or glutamate. (Right) Firing activity during MTEP ejection (0-120 
s) and glutamate (60-62 s). Cell 1 represents the cell type that did not increase baseline firing 
with MTEP. Cell 2 is an example of a cell that increased baseline firing during MTEP ejection. 
Grey box indicates the duration of MTEP ejection. Blue triangles indicate time=0 s, and are 
included to clarify the multiple single-unit files taken for baseline. 
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post-hoc P<0.01; Figure 5.7C) that lasted through the recovery period (36.2 ± 14.2%, n=5, 
Dunnett’s post-hoc P<0.05; Figure 5.8B). In contrast, single-unit firing in the other population 
significantly decreased (69.0 ± 6.8%, n=5, Dunnett’s post-hoc P<0.05; Figure 5.7C), but 
recovered (Dunnett’s post-hoc P>0.05, Figure 5.8B). The two populations also split based on 
their response to glutamate recovery ejections (t(2,8)=2.6, P=0.032; Figure 5.8B). PCR could not 
isolate reliable O2 signals during the ejection of this drug, so the effect on O2 consumption was 
not addressed. Together, these data indicated mGluR modulation does not uniformly alter 
neuronal sensitivity to glutamate throughout the NAc; what differentiates these cell responses 
requires further investigation. 
 
Dissimilarities between NOS Control over Neuronal Activity and O2 Consumption in the NAc and 
Cortex Partially Depend on nNOS Specific Pathways 
 
Since NOS inhibition produced a coupled decrease in single-unit firing and O2 
consumption in the cortex, we next ascertained the influence of NO synthesis on coupled 
responses in the NAc. We inhibited NOS using L-NAME and, as observed previously, the rate  
of single-unit firing did not change from pre-drug to drug treatment (Dunnett’s post-hoc P>0.05; 
Figure 5.7E), though significant variance differences existed between subjects (F=3.4, n=7, 
P=0.03; Figure 5.7E). This reflected as an apparent split between NAc locations either 
diminishing or sustaining cell firing responses as a result of L-NAME NOS inhibition, but without 
a correlation (Pearson’s P>0.05; Figure 5.7F). Both a diminished and sustained response 
occurred in one subject at two different locations, suggesting that the differences were not due 
to experimental error. Overall, no O2 consumption changes occurred, though two locations 
showed decreases below 50% of pre-drug values (Dunnett’s post-hoc P>0.05, Figure 5.7E-F). 
Following L-NAME washout, four of the seven locations failed to recover to pre-drug neuronal 
activity, corresponding to those locations with diminished firing during drug, again without any 
correlation between firing and O2 consumption (Pearson’s P>0.05; Figure 5.8E). This indicated 
 112 
that NOS inhibition in the NAc affects neuronal sensitivity to glutamate, but not uniformly across 
all locations.  
The microvascular environment could account for the different responses to L-NAME, a 
non-specific NOS inhibitor, which could act differently depending on the relative availabilities of 
eNOS and nNOS. Thus, we used L-ARG to selectively inhibit nNOS and remove the 
contribution of NO synthesized from NMDAR activation. As with L-NAME NOS inhibition, L-ARG 
NOS inhibition showed no significant changes to cell firing overall (Dunnett’s post-hoc P>0.05, 
n=8; Figure 5.7E), though several locations showed modest decreases without any O2 
consumption correlation (Pearson’s P>0.05; Figure 5.7F). As observed with L-NAME, two 
locations showed modest decreases in O2 consumption with no significant decreases overall 
(Dunnett’s post-hoc P>0.05; Figure 5.7E). However, contrary to the L-NAME responses, all 
locations fully recovered to baseline firing after L-ARG cleared (Dunnett’s post-hoc P>0.05; 
Figure 5.8D-E). The continued split between neuronal sensitivity to glutamate during L-NAME 
and L-ARG indicated that NOS inhibition has varied effects at different locations within the NAc. 
Additionally, the ability of neurons to recover to pre-drug levels of glutamatergic excitation is 
related to the specific inhibition of nNOS. 
 
Discussion 
In this study, we compared how local glutamate receptor antagonism and NOS inhibition 
affect neurovascular coupling between the cortex and the NAc. We used iontophoresis to limit 
glutamatergic excitation and drug effects to highly localized environments. In both the cortex 
and NAc, we found that iGluRs subtypes exerted different control over neurovascular coupling. 
Single-unit activity and O2 remained coupled during NMDAR, but not AMPAR antagonism. 
However, mGluR manipulations and NOS inhibition affected local coupling differently between 
the cortex and NAc. Additionally, mGluR and NOS pharmacological manipulations identified 
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multiple cell populations within the NAc with dissimilar responses to a given drug. Taken 
together, we concluded that glutamatergic mechanisms affect coupling between single-unit 
activity and O2 consumption at a local level in ways that differ across different brain regions. 
Here, we ejected both glutamate and pharmacological agents with iontophoresis to 
stimulate discrete environments and study local receptor modulation of neurovascular coupling. 
Importantly, glutamate iontophoresis is a selective stimulation that excludes the contributions of 
vasoactive agents released from either electrical or peripheral stimuli. Further, local drug 
ejections are advantageous over systemic drug administration in that they circumvent off target 
effects (e.g., changes in blood pressure), allow the use of drugs that cannot pass through the 
blood brain barrier (Herr et al., 2008, Belle et al., 2013, Kirkpatrick and Wightman, 2016), and 
exhibit different effects depending on whether they were administered locally or systemically 
(Bucher et al., 2014). Additionally, microenvironments in the brain are dissimilar. This technique 
can probe the heterogeneity both within and between diverse brain regions by providing a highly 
localized, chemically selective method of activating local neuronal environments with glutamate. 
Glutamate exerts the majority of its synaptic transmission influence through iGluRs 
(Traynelis et al., 2010). We confirmed that iGluR antagonism led to cell firing decreases in the 
cortex and NAc; however, glutamate evoked O2 consumption did not diminish with AMPAR 
blockade in either location. Attenuated neuronal activity during AMPAR blockade with CNQX 
agrees with electrical stimulation studies (Mathiesen et al., 1998, Nielsen and Lauritzen, 2001, 
Offenhauser et al., 2005, Hoffmeyer et al., 2007). These studies showed that CNQX inhibited 
CBF (Mathiesen et al., 1998, Nielsen and Lauritzen, 2001, Offenhauser et al., 2005, Hoffmeyer 
et al., 2007) and O2 consumption (Offenhauser et al., 2005). CBF increases O2 by delivering 
oxygenated blood, thus opposing O2 consumption. Therefore, if neuronal activity is attenuated, 
O2 consumption can appear disproportionately great for the decreased energetic demand when 
CBF is also impeded. This interpretation agrees with the O2 data obtained with CNQX in both 
brain regions and the reported studies; however, our data did not agree with the study that 
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observed decreased O2 consumption. This may reflect differences in glutamatergic versus 
electrical stimulations. Further, NMDAR antagonist effects diverged between studies. NMDAR 
antagonist MK-801 decreased CBF and neuronal activity (local field potentials) in one study 
(Nielsen and Lauritzen, 2001), but only attenuated CBF in another (Hoffmeyer et al., 2007).  
Neither MK-801 nor 2-amino-5-phosphoheptanoic acid (APH) affected CBF in third study 
(Mathiesen et al., 1998). Our data show that NMDAR antagonism decreases neuronal activity in 
both brain regions, but that the interplay of CBF and O2 differed. Without simultaneously 
measuring CBF, we cannot discern whether O2 consumption attenuated from decreased 
energetic demands or decreased energy demands coincident with unimpeded CBF, as both are 
reported possibilities. 
A number of studies report vascular responses without postsynaptic iGluR activation that 
result from enhanced astrocytic mGluR activity (Chaigneau et al., 2007, Petzold et al., 2008, 
Scott and Murphy, 2012). Multiple mGluR subtypes are located perisynaptically and activated 
only during intense activity from synaptic glutamate spillover (Cartmell and Schoepp, 2000). To 
investigate mGluR agonism under these conditions, we antagonized iGluRs to exclude their 
contribution to coupling and blocked the primary astrocytic glutamate transporter, GLT-1, to 
increase extracellular glutamate concentrations. Single-unit activity diminished further than from 
NMDAR or AMPAR antagonism alone, in agreement with other studies (Pettit et al., 1997, Frick 
et al., 2001, Nielsen and Lauritzen, 2001, Hoffmeyer et al., 2007). The difference in O2 usage 
following local glutamate stimulations between the NAc and cortex during drug delivery (i.e., 
decoupling from single-unit activity and remaining coupled, respectively) may indicate a 
difference in how the NAc neuronal architecture responds to increased extracellular glutamate. 
Indeed, the greater average density of astrocytes in the neostriatum as compared to the cortex 
would provide additional GLT-1 transporters to clear excess glutamate (Savchenko et al., 2000).  
Neurovascular effects from downstream mGluR activation usually are studied using 
specific ligand agonism. Group I/II mGluR agonist ACPD causes vasodilation (Fergus and Lee, 
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1997, Zonta et al., 2003, Stobart et al., 2013), which may be responsible for the steady O2 
decrease that accompanied ACPD ejections (example shown in Figure 5.1C). It is worth noting 
that the evoked O2 consumption in the NAc attenuated only slightly with ACPD relative to control 
despite the steady vasodilative O2 decline (Dunnett’s post-hoc: P=0.059, Figure 5.7B), but these 
data were pooled between cell populations exhibiting different levels of firing attenuation and, by 
extension, energetic demands (Figure 5.7D). Additionally, mGluR activation can lead to a host 
of responses through astrocytes that lead to either vasoconstriction or vasodilation depending 
on the predominating downstream process (Attwell et al., 2010). Ultimately, our results indicated 
that in the cortex, and a subset of NAc cells, mGluR agonism led to decoupled responses 
between single-unit activity and local O2 consumption. 
Several physical differences between the cortex and NAc can account for the dissimilar 
responses to mGluR agonism. ACPD has agonistic effects at all three mGluR groups (Cartmell 
and Schoepp, 2000), though most strongly at groups I and II, and therefore differential effects 
could result from the relative quantities of these mGluR types in the discrete recording areas. 
This is especially important to consider with high resolution techniques, as mGluR subtypes 
express in different relative ratios throughout the brain and across subcellular structures (e.g., 
axon, terminals) (Testa et al., 1994, Petralia et al., 1996, Mitrano and Smith, 2007). Of particular 
interest is mGluR2, which has been shown to depress synaptic transmission via presynaptic 
inhibition in both cortex and NAc (Burke and Hablitz, 1994, Xi et al., 2002). This is consistent 
with our results in the cortex, where this mGluR is more prevalent (Testa et al., 1994). Thus, the 
high spatial resolution of our multimodal sensor is likely detecting physically heterogeneous 
environments where neurovascular coupling is modulated differentially through mGluRs.  
An important difference between the somatosensory cortex and the NAc is the existence 
of dopaminergic terminals in the latter brain region. The influence of mGluRs extends to 
mediating dopaminergic function in the NAc (Verma and Moghaddam, 1998, Bruton et al., 
1999). Specifically, mGluR agonism raises basal striatal dopamine levels, which can augment or 
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diminish neuronal excitability (Surmeier et al., 2007, Cachope and Cheer, 2014). We observed 
extended (>30 s) catechol-like signals concomitant with ACPD ejections in some NAc locations 
but no cortical locations (data not shown). We were unable to definitively identify whether the 
signal was dopamine through our protocol. Though our multimodal sensor is capable of probing 
the relationship between mGluRs, dopamine, and O2, it was outside the scope of this work. 
We also considered whether the different cell responses with ACPD were from use of 
different ejection currents and thus inconsistent absolute concentrations of drug delivery. 
Studies have reported concentration-dependent effects from ACPD use (Lovinger, 1991, Taber 
and Fibiger, 1995, Verma and Moghaddam, 1998), but these effects compared µM – mM 
concentration ranges, which far exceeds concentrations delivered through iontophoresis 
(Kirkpatrick et al., 2014). Therefore, we do not believe that ejecting ACPD at different currents is 
responsible for the dissimilar responses observed in neuronal activity and O2 consumption. 
To address the disparate NAc responses with mGluR agonism, we investigated the most 
highly expressed mGluR in this region, mGluR5 (Testa et al., 1994, Romano et al., 1995). 
Antagonized mGluR5 attenuated neuronal firing, which supports the suppression of glial 
mGluR5-mediated NMDAR activation (D'Ascenzo et al., 2007). Cell firing attenuated regardless 
of whether or not MTEP elicited an increase in spontaneous basal firing rates (Figure 5.9). In 
both mGluR agonist and mGluR5 antagonist cohorts, we observed recording locations that did 
not recover from attenuated single-unit activity, contrasting with studies indicating that mGluR5 
activation is required for long-term depression (Huber et al., 2001, Brebner et al., 2005); 
however, these studies evoked activity through electrical afferent stimulations as opposed to our 
localized approach. A more thorough investigation of local mGluR pharmacology in the NAc 
would elucidate whether the observed differences are due to heterogeneous recording 
environments or drug specificity. 
We did not expect NOS to affect neuronal firing, as electrical stimulation studies showed 
that NOS inhibition does not alter synaptic activity (Offenhauser et al., 2005, Hoffmeyer et al., 
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2007). This agreed with data in the NAc during both nonspecific NOS and specific nNOS 
inhibition, but not in all locations (Figure 5.7F). However, a study using L-NAME iontophoresis 
observed both excitatory and inhibitory effects on cell firing within the subthalamic nucleus 
(Sardo et al., 2006), which may indicate that observed single-unit activity suppression in both 
the cortex and NAc may result from local environmental factors. Interestingly, neuronal activity 
suppression persisted through a recovery epoch with nonspecific NOS inhibition and recovered 
with nNOS inhibition, indicating that eNOS may assist recovery from NO-based neuronal 
inhibition in the NAc. Taken together, these results indicate that local NOS inhibition likely 
affects neuronal sensitivity to glutamate differently depending on the surrounding environment. 
In our previous work, L-NAME iontophoresis exclusively diminished events of local O2 
increases attributed to blood flow (Bucher et al., 2014). In the NAc, where NOS inhibition did not 
significantly alter neuronal firing or O2 consumption, these data agreed. In the cortex, however, 
O2 consumption decreased. This may result from either the attenuated cell firing in combination 
with attenuated CBF, as observed with CNQX, or because of the known modulatory role of NO 
in the somatosensory cortex (Lindauer et al., 1999). Briefly, increases in NO promotes 
quantified increases in vasodilation when NO acts as a modulator rather than requiring a 
threshold NO concentration to elicit vasoactivity. Therefore, inhibiting NO synthesis in the cortex 
leads to diminished O2 consumption as blood vessels become constricted.  
The capability to selectively excite and pharmacologically manipulate local neuronal 
populations enables the study of neurovascular coupling without off-target effects. However, it is 
important to recognize the weaknesses of this methodology. Local glutamate stimulation is less 
powerful than electrical stimulation, thus evoked O2 changes are modest and can be obscured 
by natural O2 transients (Figure 5.2, top)(Walton et al., 2016). Combined with the high spatial 
resolution and natural heterogeneity of neurovascular environments, these measurements can 
suffer in statistical power. G-G corrections in our ANOVA analysis indicated populations that 
reached significance in post-hoc testing without achieving significant variance between 
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treatments (e.g., cortical NOS inhibition effects). Therefore, our sensors require more recording 
locations to achieve statistical confidence. 
The pharmacological agents introduce further complexities. Not all drugs dissolve in inert 
solvents at appropriate concentrations or eject with low ionic strength (Herr et al., 2008, 
Kirkpatrick and Wightman, 2016). Unique to our coupling of iontophoresis to FSCV, some drug 
ejection profiles obscure color plot data beyond that which PCR can extract (MTEP, vide supra). 
An alternative is to using higher solubility drugs, which may be inferior with respect to potency or 
specificity. 
Despite these disadvantages, we used iontophoresis to study differences in glutamate 
evoked neurovascular coupling by exciting local neuronal populations and locally administering 
pharmacological agents. Glutamate exerts similar effects through iGluRs between the cortex 
and NAc, but we identified disparate mechanisms of action between these two areas with 
respect to manipulating mGluRs and NOS. These data provide evidence that compromising the 
functionality of glutamate receptors can disrupt the coupling between neuronal activity and O2. 
Further, they illustrate location dependent heterogeneity in these responses that techniques like 
fMRI might overlook during interpretations of neurovascular coupling. 
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